Ophthalmology – Retinoblastoma

Basics

Description

Retinoblastoma (RB) is the most common primary intraocular malignancy of childhood.

It arises from the developing retina and usually presents before:

5 years of age, most commonly in the first few years of life.

It may be:

• Unilateral
• Bilateral
• Unifocal
• Multifocal
• Heritable or nonheritable

The most important presenting signs are:

• Leukocoria
• Strabismus

Any child with either finding requires:

Urgent dilated ophthalmic examination.

Key Clinical Priorities

Management follows three priorities:

1. Save life
2. Save the eye
3. Preserve useful vision

Cosmesis is secondary to these goals.

Epidemiology

Retinoblastoma occurs in approximately:

1 in 15,000–20,000 live births

Worldwide, several thousand children are diagnosed each year.

In high-resource settings, survival exceeds:

95%

when disease is confined to the eye and treated promptly.

Survival remains substantially lower in regions where diagnosis is delayed and extraocular disease is more common.

Age at Presentation

Typical patterns:

Bilateral/Heritable RB

Presents:

• Earlier
• Often during infancy
• Frequently multifocal

Unilateral/Nonheritable RB

Presents:

• Somewhat later
• Usually as a single tumor

Genetics

The fundamental genetic abnormality involves:

RB1 tumor suppressor gene

located at:

Chromosome 13q14

Knudson Two-Hit Hypothesis

Retinoblastoma provided the classic model for the:

Two-hit hypothesis

Both copies of RB1 must be functionally inactivated in a retinal precursor cell for tumor formation.

Heritable Retinoblastoma

Heritable disease involves a pathogenic germline RB1 variant.

These children have the first “hit” in all cells and require only a second somatic mutation in a retinal cell.

Features include:

• Usually bilateral disease
• Often multifocal tumors
• Earlier presentation
• Increased risk of trilateral retinoblastoma
• Increased lifelong risk of second primary malignancies

Important Modern Genetic Point

Not all unilateral retinoblastoma is nonheritable.

Approximately:

10–15% of children with apparently unilateral RB may carry a germline RB1 pathogenic variant

Therefore:

Genetic counseling and RB1 testing should be offered to essentially all affected children when available.

Nonheritable Retinoblastoma

In nonheritable disease:

• Both RB1 hits occur within the tumor
• Disease is usually unilateral and unifocal
• The mutation is not present throughout the body

However, mosaic germline disease can complicate classification.

Family History

Only a minority of patients have an obvious family history.

A negative family history does:

Not exclude heritable retinoblastoma

because germline mutations may arise de novo.

Inheritance

Heritable RB follows an:

Autosomal dominant cancer predisposition pattern

with high but incomplete penetrance depending on the variant.

An affected individual with a germline RB1 variant may transmit the variant to:

50% of offspring.

Genetic Counseling

Families should receive counseling regarding:

• Germline testing
• Recurrence risk
• Testing of parents and siblings
• Future pregnancy options
• Preimplantation genetic testing when desired
• Prenatal genetic diagnosis when appropriate

Modern counseling should support reproductive choice rather than recommend avoidance of pregnancy.

Prenatal Considerations

In a family with a known pathogenic RB1 variant, options may include:

• Prenatal genetic testing
• Preimplantation genetic testing
• Targeted fetal imaging in selected high-risk pregnancies

Fetal ultrasound alone is:

Not sufficiently sensitive to exclude retinoblastoma.

Delivery planning and prompt postnatal ophthalmic examination are more important.

Newborn Screening in High-Risk Families

Infants with:

• Known familial RB1 mutation
• A parent with heritable retinoblastoma
• A sibling with heritable disease

should undergo:

Prompt ophthalmic examination after birth

often within the first days to weeks of life depending on risk and local protocol.

13q Deletion Syndrome

Large deletions involving chromosome 13q may include:

RB1

and produce retinoblastoma associated with developmental abnormalities.

Features may include:

• Developmental delay
• Growth abnormalities
• Craniofacial dysmorphism
• Limb abnormalities

This should prompt:

Clinical genetics evaluation.

Pathophysiology

Loss of functional RB1 disrupts:

• Cell-cycle regulation
• Retinal differentiation
• Control of proliferation

allowing malignant retinal cells to proliferate.

Histology

Retinoblastoma is composed of:

• Small round blue tumor cells
• Hyperchromatic nuclei
• Scant cytoplasm
• Variable necrosis and calcification

Flexner-Wintersteiner Rosettes

A classic sign of photoreceptor differentiation is:

Flexner-Wintersteiner rosettes

These consist of tumor cells arranged around:

• A central lumen

They are characteristic but not present in every tumor.

Homer Wright Rosettes

Homer Wright-type rosettes may also be seen, reflecting:

• Neuroblastic differentiation

but are less specific.

Calcification

Retinoblastoma commonly contains:

Intratumoral calcification

This is an important imaging clue.

Growth Patterns

Retinoblastoma may grow:

Endophytically

Toward:

• Vitreous cavity

Often associated with:

• Vitreous seeds

Exophytically

Toward:

• Subretinal space

Often associated with:

• Exudative retinal detachment
• Subretinal seeds

Diffuse Infiltrating

A flat infiltrative pattern that may mimic:

• Uveitis
• Endophthalmitis
• Retinal detachment

Presenting Features

The two most common presenting signs are:

Leukocoria

White pupillary reflex

This is the most common presentation.

Strabismus

May result from:

• Macular tumor
• Reduced central vision
• Sensory visual loss

Other Presentations

Less common manifestations include:

• Red painful eye
• Secondary glaucoma
• Hyphema
• Pseudohypopyon
• Cataract
• Vitreous hemorrhage
• Orbital cellulitis-like presentation
• Proptosis in advanced extraocular disease

Leukocoria – Differential Diagnosis

Important causes include:

• Retinoblastoma
• Coats disease
• Persistent fetal vasculature
• Cataract
• Retinal detachment
• Toxocariasis
• Familial exudative vitreoretinopathy
• Retinopathy of prematurity

Because retinoblastoma is potentially fatal:

It must be excluded urgently.

Examination

Children usually require:

Examination under anesthesia (EUA)

for complete assessment.

Document:

• Number of tumors
• Tumor size
• Location
• Distance from fovea and disc
• Vitreous seeds
• Subretinal seeds
• Retinal detachment
• Anterior segment involvement

Fundus Appearance

Retinoblastoma typically appears as:

• Creamy white
• Elevated
• Retinal mass

with possible:

• Calcification
• Surface vessels
• Retinal detachment
• Vitreous/subretinal seeding

Ultrasonography

B-scan ultrasonography is highly useful.

It can demonstrate:

• Intraocular mass
• Retinal detachment
• Highly reflective calcification

Calcification strongly supports retinoblastoma in the appropriate clinical setting.

MRI

MRI of the:

Brain and orbits with contrast

is preferred for evaluating:

• Optic nerve involvement
• Extraocular extension
• Intracranial disease
• Trilateral retinoblastoma

CT

CT can demonstrate calcification but is generally:

Avoided when possible

especially in children with heritable RB because ionizing radiation may increase lifetime second-cancer risk.

Ultrasound and MRI usually provide sufficient diagnostic information.

Fundus Photography

Wide-field retinal photography helps document:

• Tumor size
• Location
• Response to treatment
• New lesions

OCT

Handheld or conventional OCT may help assess:

• Small macular lesions
• Foveal anatomy
• Tumor regression
• Treatment-related retinal damage

It is an adjunct rather than the primary diagnostic test.

Fluorescein Angiography

FA may demonstrate:

• Tumor vasculature
• Treatment effects

but is not essential for diagnosis in most cases.

Critical Diagnostic Rule

Do not perform fine-needle aspiration or intraocular biopsy of suspected retinoblastoma.

This can create:

• Extraocular tumor seeding
• Orbital spread
• Potential metastatic risk

Diagnosis is usually established clinically and with imaging.

International Classification of Retinoblastoma

The International Classification of Retinoblastoma (ICRB) groups intraocular disease by likelihood of eye salvage.

Exact definitions vary slightly between classification versions, but the practical framework is:

Group A

Small tumors away from critical structures.

Typically:

• ≤3 mm
• No vitreous or subretinal seeds

These have an excellent eye-salvage prognosis.

Group B

Larger or more posterior tumors but:

• No significant vitreous/subretinal seeding

May include:

• Macular lesions
• Juxtapapillary lesions
• Limited subretinal fluid

Group C

Localized:

• Vitreous seeds
• Subretinal seeds

close to the primary tumor.

Group D

Diffuse or extensive:

• Vitreous seeding
• Subretinal seeding

These eyes are more difficult to salvage.

Group E

Very advanced intraocular disease with features suggesting poor visual potential or increased treatment complexity.

Examples include:

• Tumor occupying much of the globe
• Neovascular glaucoma
• Massive hemorrhage
• Anterior segment involvement
• Extensive retinal detachment
• Other advanced features

Important Staging Distinction

ICRB groups A–E classify:

Intraocular disease and likelihood of eye salvage

They are not the same as:

• AJCC TNM staging
• Histopathologic metastatic-risk staging

AJCC TNM

Modern multidisciplinary care may also use:

AJCC TNM staging

to describe:

• Intraocular extent
• Regional spread
• Metastatic disease

This is particularly important in:

• Extraocular retinoblastoma
• Oncology outcome reporting

Differential Diagnosis

The major differential diagnoses include:

• Coats disease
• Persistent fetal vasculature
• Toxocariasis
• Familial exudative vitreoretinopathy
• Retinopathy of prematurity
• Retinal detachment
• Astrocytic hamartoma
• Medulloepithelioma
• Cataract

Retinoblastoma vs Coats Disease

Retinoblastoma

• White retinal mass
• Calcification common
• Vitreous/subretinal seeds possible

Coats Disease

• Telangiectatic retinal vessels
• Massive yellow lipid exudation
• Exudative retinal detachment
• No true retinal tumor

Coats disease remains one of the classic:

Pseudoretinoblastomas.

Treatment Principles

Management is individualized according to:

• Unilateral vs bilateral disease
• ICRB group
• Tumor number
• Tumor location
• Vitreous/subretinal seeds
• Visual potential
• Germline status
• Extraocular extension

Treatment should be performed in a:

Specialized retinoblastoma center.

Focal Therapy

Focal treatment is most useful for:

• Small tumors
• Residual tumors after chemotherapy
• Recurrent localized disease

Options include:

• Laser photocoagulation/thermotherapy
• Cryotherapy

Laser / Thermotherapy

Laser is often used for:

• Small posterior tumors
• Residual tumor after chemotherapy

It induces:

• Tumor vascular closure
• Thermal destruction

Cryotherapy

Cryotherapy is particularly useful for:

• Small peripheral tumors
• Anterior lesions

It is less suitable for lesions near:

• Fovea
• Optic disc

because of scar-related visual damage.

Systemic Intravenous Chemotherapy

Traditional chemoreduction uses combinations such as:

• Vincristine
• Etoposide
• Carboplatin

Systemic chemotherapy remains important particularly for:

• Bilateral disease
• Multifocal disease
• Very young infants in selected settings
• Extraocular disease
• High-risk histopathology after enucleation
• Patients where systemic coverage is advantageous

It is no longer the only major globe-salvage strategy.

Intra-Arterial Chemotherapy

Intra-arterial chemotherapy (IAC) has transformed retinoblastoma management.

A catheter is placed into the:

Ophthalmic artery

and chemotherapy is delivered directly to the affected eye.

Common agents include:

• Melphalan
• Topotecan
• Carboplatin

IAC Indications

IAC is commonly used for:

• Unilateral Group B–D disease
• Selected advanced eyes
• Recurrent disease
• Eyes poorly responsive to systemic chemotherapy

It may also be used in selected bilateral cases.

Advantages of IAC

Advantages include:

• High intraocular drug concentration
• Reduced systemic exposure
• Excellent globe salvage in many advanced eyes

IAC Complications

Potential complications include:

• Retinal vascular occlusion
• Choroidal ischemia
• Ophthalmic artery injury
• Eyelid edema
• Cranial nerve effects
• Rare systemic vascular complications

It requires an experienced:

Interventional neuroradiology/ocular oncology team.

Intravitreal Chemotherapy

Intravitreal chemotherapy is now a major treatment for:

Vitreous seeds

Common agents include:

• Melphalan
• Topotecan

Safety-Enhanced Injection Technique

Intravitreal injection in retinoblastoma requires specialized techniques to minimize tumor escape, including:

• Tumor-free injection site
• Controlled needle entry
• Cryotherapy to needle tract in some protocols

This should only be performed by:

Experienced retinoblastoma specialists.

Subretinal Chemotherapy

Highly specialized centers may also use:

• Subretinal chemotherapy

for selected persistent subretinal seeds.

This is not routine first-line therapy everywhere.

Enucleation

Enucleation remains essential for advanced eyes with poor visual potential or high-risk features.

Common indications include:

• Many Group E eyes
• Painful blind eye
• Neovascular glaucoma
• Massive tumor
• Anterior segment invasion
• Severe hemorrhage
• Failure of conservative therapy

Enucleation Principle

When enucleation is required, the optic nerve should be removed with:

As long a segment as safely possible

because histopathologic optic nerve invasion affects metastatic risk.

High-Risk Histopathology

After enucleation, pathology should specifically assess for:

• Postlaminar optic nerve invasion
• Massive choroidal invasion
• Scleral invasion
• Extrascleral extension
• Anterior segment invasion

These features may indicate need for:

Adjuvant systemic chemotherapy.

Plaque Radiotherapy

Plaque brachytherapy may be useful for:

• Localized recurrent tumors
• Residual tumors
• Selected tumors refractory to other local therapy

Its role is now more limited than historically.

External Beam Radiotherapy

External beam radiation is now:

Generally avoided whenever possible

because it increases risks of:

• Second primary malignancies
• Orbital/facial growth disturbance
• Cataract
• Radiation retinopathy
• Radiation optic neuropathy

The risk is especially important in:

Heritable RB1 mutation carriers.

Trilateral Retinoblastoma

Children with heritable retinoblastoma have increased risk of an intracranial primitive neuroectodermal tumor, most often:

• Pinealoblastoma

and less commonly a suprasellar tumor.

This combination is called:

Trilateral retinoblastoma

Brain MRI Surveillance

A brain MRI is generally obtained:

At diagnosis

particularly in:

• Bilateral disease
• Known heritable RB
• Very young children

Some centers perform serial MRI screening every several months until approximately age 5 in heritable disease, while practices vary because the optimal surveillance schedule remains debated.

Second Primary Malignancies

Patients with germline RB1 mutations have an increased lifetime risk of cancers such as:

• Osteosarcoma
• Soft-tissue sarcoma
• Melanoma
• Other epithelial and mesenchymal malignancies

Risk is especially increased after:

Ionizing radiation exposure.

Long-Term Survivorship

Heritable RB survivors require:

• Lifelong awareness of second malignancy risk
• Avoidance of unnecessary ionizing radiation
• Appropriate age- and symptom-based cancer surveillance

Routine whole-body imaging is not automatically indicated for every asymptomatic survivor.

Follow-Up of the Eyes

Children require frequent examination during and after treatment.

Early follow-up may be:

• Every few weeks
• Monthly

depending on:

• Tumor activity
• Age
• Treatment modality

Intervals are gradually extended after sustained regression.

Examination Under Anesthesia

EUA is commonly required until the child is sufficiently cooperative for complete office examination.

There is:

No rigid age cutoff

because this depends on:

• Development
• Cooperation
• Tumor complexity

Tumor Regression

Regressed tumors may become:

• Calcified
• Atrophic
• Scar-like

Different regression patterns occur depending on:

• Treatment modality
• Tumor type

A regressed scar still requires surveillance for:

• Recurrence
• New tumors in genetically susceptible children

Retinoma / Retinocytoma

A benign or spontaneously arrested RB1-related lesion called:

Retinoma/retinocytoma

may occur in some germline mutation carriers.

It can appear:

• Gray
• Calcified
• Translucent

and requires surveillance because malignant transformation can rarely occur.

Visual Prognosis

Visual outcome depends strongly on:

• Foveal involvement
• Optic disc involvement
• Tumor size
• Retinal detachment
• Treatment-related retinal injury

Small peripheral tumors may be treated with:

Excellent visual preservation.

Large macular tumors often cause permanent central visual loss despite successful tumor control.

Amblyopia

Children with unilateral or asymmetric disease are at high risk for:

Amblyopia

After tumor control, visual rehabilitation may include:

• Refractive correction
• Occlusion therapy
• Other amblyopia treatment

when safe and appropriate.

Protective Eyewear

Children with one functional eye should use:

Protective polycarbonate eyewear

to reduce trauma risk to the better-seeing eye.

Prognosis

In high-resource settings, intraocular retinoblastoma has an:

Excellent life prognosis

when detected before extraocular spread.

The major threats to survival are:

• Optic nerve extension
• Extrascleral extension
• CNS involvement
• Hematogenous metastasis

Extraocular Retinoblastoma

Extraocular disease may spread to:

• Orbit
• Brain
• Bone
• Bone marrow

This requires aggressive multidisciplinary management with:

• Systemic chemotherapy
• High-dose chemotherapy in selected cases
• Radiotherapy when necessary
• Surgical management

Poor Prognostic Features

Poorer survival is associated with:

• Delayed diagnosis
• Extraocular extension
• Postlaminar optic nerve invasion
• Massive choroidal invasion
• Scleral/extrascleral invasion
• Metastatic disease

Complications

Potential complications include:

• Visual loss
• Loss of the eye
• Amblyopia
• Cataract
• Retinal detachment
• Vitreous hemorrhage
• Glaucoma
• Radiation complications
• Chemotherapy toxicity
• Second primary malignancy
• Trilateral retinoblastoma

Ophthalmology Pearls

• Retinoblastoma is the most common primary intraocular malignancy of childhood.
• The two most common presenting signs are leukocoria and strabismus; either requires urgent dilated examination.
• The disease results from biallelic inactivation of the RB1 tumor suppressor gene on chromosome 13q14.
• Bilateral and multifocal disease should be considered heritable until proven otherwise, but even apparently unilateral RB can carry a germline RB1 mutation.
• Offer genetic counseling and RB1 testing when available because results affect family screening, future pregnancies, trilateral RB risk, and lifelong cancer surveillance.
• Retinoblastoma typically appears as a white retinal mass with calcification, often associated with retinal detachment or vitreous/subretinal seeds.
• B-scan ultrasonography is valuable for detecting calcification; MRI brain/orbits evaluates optic nerve, extraocular, and intracranial disease.
• Avoid routine CT when MRI and ultrasound are sufficient because children—especially germline RB1 carriers—should minimize unnecessary ionizing radiation.
• Never perform intraocular biopsy or fine-needle aspiration of suspected retinoblastoma because of the risk of tumor seeding.
• The ICRB A–E classification estimates intraocular disease severity and likelihood of globe salvage; it is not equivalent to metastatic staging.
• Modern treatment increasingly uses intra-arterial chemotherapy for globe salvage and intravitreal melphalan/topotecan for vitreous seeds.
• Systemic vincristine/etoposide/carboplatin remains important in bilateral, multifocal, extraocular, and selected high-risk disease.
• Enucleation remains the safest treatment for many advanced Group E eyes with poor visual potential or high-risk features.
• Histopathology after enucleation must assess for postlaminar optic nerve invasion, massive choroidal invasion, scleral and extrascleral extension, which may require adjuvant chemotherapy.
• External beam radiotherapy is now largely avoided because of second malignancy risk and orbital/facial growth abnormalities, especially in heritable disease.
• Heritable RB predisposes to trilateral retinoblastoma and lifelong second primary cancers.
• Modern management follows the priorities: save life → save eye → preserve vision.
• Long-term care includes ocular surveillance, amblyopia treatment, protective eyewear when only one eye sees well, genetic counseling, and survivorship monitoring for second malignancies.

Ophthalmology – Coats Disease

Basics

Description

Coats disease is an idiopathic retinal vascular disorder characterized by:

• Retinal telangiectasia
• Aneurysmal retinal vessels
• Breakdown of the blood-retinal barrier
• Massive intraretinal and subretinal lipid exudation
• Progressive exudative retinal detachment in advanced disease

Classic Coats disease is usually:

• Unilateral
• Sporadic
• Nonhereditary
• Seen predominantly in boys and young males
• Unassociated with systemic disease

The major pediatric diagnostic concern is:

Retinoblastoma, because both can present with leukocoria and retinal detachment.

Epidemiology

Most patients present during:

Childhood, often before age 10

but Coats disease can present:

• In adolescence
• In adulthood
• Rarely later in life

Adult-onset disease is often:

• More localized
• Less exudative
• More slowly progressive

than childhood disease.

Sex and Laterality

Typical epidemiologic pattern:

• Strong male predominance
• Unilateral in the great majority of cases

True bilateral classic Coats disease is extremely unusual.

Bilateral Coats-like retinopathy should prompt evaluation for:

• Inherited retinal vascular disorders
• Systemic syndromes
• Other causes of exudative retinopathy

Genetics

Classic Coats disease is generally:

Sporadic and nonhereditary

Somatic abnormalities involving the:

NDP signaling pathway

have been proposed in some cases, supporting a retinal vascular developmental mechanism.

Routine genetic testing is:

Not required for typical unilateral Coats disease.

When to Consider Genetic/Systemic Evaluation

Consider broader evaluation when there is:

• Bilateral retinal telangiectasia/exudation
• Neurologic abnormalities
• Growth abnormalities
• Skeletal or muscular disease
• Strong family history
• Atypical phenotype

Important Coats-like conditions include:

• Coats plus syndrome
• Familial exudative vitreoretinopathy
• Retinopathy of prematurity
• Incontinentia pigmenti
• Facioscapulohumeral muscular dystrophy-associated retinopathy
• Norrie disease-related retinopathy

Pathophysiology

The fundamental abnormality is:

Retinal vascular incompetence

with:

• Telangiectatic capillaries
• Aneurysmal dilatation
• Abnormal endothelial barrier
• Capillary nonperfusion

This leads to leakage of:

• Lipid
• Protein
• Fluid

into the retina and subretinal space.

Retinal Exudation

Chronic vascular leakage causes:

• Intraretinal hard exudates
• Macular exudation
• Subretinal exudation
• Exudative retinal detachment

Lipid accumulation may become extensive and yellow-white.

Retinal Ischemia

Areas of peripheral retinal nonperfusion may coexist with telangiectasia.

Ischemia contributes to:

• Progressive vascular abnormality
• VEGF production
• Rare neovascularization

Distribution

The abnormal vessels most commonly involve:

Temporal peripheral retina

but disease may extend:

• Inferiorly
• Superiorly
• Nasally
• Circumferentially

More extensive disease tends to occur in younger children.

Shields Classification

A commonly used staging system is:

Stage 1

Retinal telangiectasia only

No significant exudation.

Stage 2

Telangiectasia + exudation

Stage 2A

Exudation does not involve the fovea

Stage 2B

Exudation involves the fovea

This distinction is important because foveal involvement markedly worsens visual prognosis.

Stage 3

Telangiectasia + exudation + exudative retinal detachment

Stage 3A

Subtotal retinal detachment

Stage 3B

Total retinal detachment

Some classifications further divide stage 3A according to foveal involvement.

Stage 4

Total retinal detachment + secondary glaucoma

Usually represents advanced disease.

Stage 5

End-stage disease with:

• Blind eye
• Phthisis
• Severe chronic retinal detachment
• Sometimes chronic pain

Clinical Presentation

Typical presenting features include:

• Decreased vision
• Strabismus
• Leukocoria
• Abnormal red reflex
• Occasionally ocular pain in advanced disease

Some patients are discovered incidentally.

Leukocoria

Any child with:

Leukocoria or an abnormal red reflex

requires urgent ophthalmic evaluation.

Important causes include:

• Retinoblastoma
• Coats disease
• Persistent fetal vasculature
• Cataract
• Retinal detachment
• Toxocariasis

Strabismus

Strabismus may develop because of:

• Macular exudation
• Reduced visual acuity
• Sensory disruption

In young children, strabismus may be the first sign noted by parents.

Visual Loss

Reduced vision may result from:

• Foveal exudation
• Macular edema
• Subfoveal lipid
• Exudative retinal detachment
• Macular fibrosis
• Secondary amblyopia

Fundus Findings

Typical examination reveals:

• Telangiectatic retinal vessels
• Aneurysmal vascular dilatations
• Yellow intraretinal lipid exudation
• Peripheral capillary nonperfusion
• Exudative retinal detachment

Telangiectasia

Coats vessels may appear:

• Irregularly dilated
• Aneurysmal
• Light-bulb shaped
• Tortuous

They are often located in the:

Temporal peripheral retina

Hard Exudates

Lipid exudates may form:

• Circinate rings around abnormal vessels
• Dense macular deposits
• Extensive subretinal yellow material

Macular exudation is a major predictor of visual outcome.

Exudative Retinal Detachment

Progressive leakage may produce:

• Localized subretinal fluid
• Bullous subtotal detachment
• Total exudative retinal detachment

No retinal break is required.

Advanced Anterior Segment Findings

Advanced disease may cause:

• Iris neovascularization
• Secondary glaucoma
• Cataract
• Shallow anterior chamber
• Corneal edema

Chronic total retinal detachment may eventually produce:

Phthisis bulbi

Cholesterol Crystals

Advanced cases may occasionally demonstrate:

• Cholesterol crystals in the subretinal space
• Anterior chamber cholesterolosis

These reflect chronic lipid-rich exudation.

Diagnosis

Diagnosis is primarily:

Clinical + multimodal retinal imaging

The most important task is to:

Exclude retinoblastoma before undertaking treatment

in a child with leukocoria or exudative retinal detachment.

Examination Under Anesthesia

Young children may require:

Examination under anesthesia (EUA)

for complete:

• Dilated retinal examination
• Scleral depression
• Photography
• Fluorescein angiography
• Laser or cryotherapy

EUA is especially useful when office examination is incomplete.

Fundus Photography

Wide-field photography is valuable for:

• Baseline documentation
• Mapping telangiectasia
• Monitoring exudation
• Assessing treatment response

Fluorescein Angiography

Wide-field fluorescein angiography is one of the most useful tests in Coats disease.

It demonstrates:

• Telangiectatic vessels
• Aneurysms
• Peripheral nonperfusion
• Late leakage
• Previously occult abnormal vascular beds

FA helps define the area requiring:

Laser ablation.

Optical Coherence Tomography

OCT is particularly useful for macular assessment.

It may demonstrate:

• Intraretinal fluid
• Subretinal fluid
• Hard exudates
• Foveal distortion
• Epiretinal fibrosis

OCT is important for:

Visual prognosis and treatment monitoring.

OCT Angiography

OCTA may demonstrate:

• Abnormal superficial/deep vascular networks
• Capillary nonperfusion

but currently does not replace wide-field FA for mapping peripheral Coats vessels.

Ultrasonography

B-scan ultrasonography is especially important when:

• Dense exudation obscures the fundus
• Total retinal detachment is present
• Retinoblastoma is in the differential

Coats disease typically shows:

• Retinal detachment
• Subretinal exudation

without the classic intratumoral calcification of retinoblastoma.

Important Caveat About Calcification

Absence of calcification:

Does not by itself prove Coats disease

and the diagnosis of retinoblastoma should never be excluded on a single imaging feature.

The entire clinical and imaging picture must be considered.

Differential Diagnosis

The most important differential is:

Retinoblastoma

Other considerations include:

• Familial exudative vitreoretinopathy
• Persistent fetal vasculature
• Retinopathy of prematurity
• Retinal hemangioblastoma
• Retinal vasoproliferative tumor
• Toxocariasis
• Norrie disease
• Incontinentia pigmenti
• Retinal detachment of another cause
• Radiation retinopathy
• Severe retinal vasculitis

Coats Disease vs Retinoblastoma

Coats Disease

Typically:

• Male child
• Unilateral
• Telangiectatic retinal vessels
• Massive yellow lipid exudation
• Exudative retinal detachment
• Usually no intraocular calcified tumor

Retinoblastoma

Typically:

• Intraocular retinal mass
• Calcification common
• Tumor-associated retinal detachment
• Vitreous or subretinal seeds may be present

Because missing retinoblastoma has major consequences:

Any diagnostic uncertainty warrants evaluation by an ocular oncology or pediatric retinal specialist.

Coats Disease vs FEVR

Familial exudative vitreoretinopathy tends to show:

• Bilateral disease
• Peripheral avascular retina
• Retinal dragging
• Falx folds
• Family history in some patients

Classic Coats disease is overwhelmingly:

Ophthalmology – Relative Afferent Pupillary Defect (RAPD)

Basics

Description

A relative afferent pupillary defect (RAPD) is an asymmetry in the pupillary light response caused by unequal afferent visual input from the two eyes.

It is detected with the:

Swinging flashlight test

and indicates asymmetric dysfunction somewhere in the:

• Retina
• Optic nerve
• Optic chiasm in selected asymmetric lesions
• Optic tract in selected lesions

The older term:

Marcus Gunn pupil

is still encountered, but RAPD is preferred.

Key Clinical Concept

An RAPD is not primarily a disorder of the pupil itself.

It is a sign of:

Asymmetric afferent visual pathway dysfunction

When light is moved from the better eye to the more affected eye, the total afferent signal reaching the pretectal nuclei falls.

As a result:

Both pupils constrict less or relatively dilate

even though the light is now shining directly into one eye.

Normal Pupillary Light Reflex

The afferent pathway is:

Retina → optic nerve → chiasm → optic tract → pretectal nuclei

From the pretectal nuclei, signals project bilaterally to:

• Edinger-Westphal nuclei

The efferent pathway is:

CN III → ciliary ganglion → short ciliary nerves → iris sphincter

Because pretectal output is bilateral, light entering one normal eye normally causes:

• Direct constriction of that pupil
• Consensual constriction of the opposite pupil

What an RAPD Means

An RAPD indicates that one eye provides:

Less afferent pupillary input than the other

It therefore depends on:

Inter-eye asymmetry

rather than absolute visual function.

Important Consequence

A patient with severe bilateral but symmetric optic neuropathy may have:

No RAPD

because both afferent pathways are equally impaired.

Conversely, a patient with normal or near-normal visual acuity may have an RAPD if there is:

• Significant peripheral retinal disease
• Optic nerve dysfunction

RAPD Is a Relative Sign

The defect is named according to the eye with:

Less afferent input

For example:

Left RAPD

means light entering the left eye produces less pupillary constriction than light entering the right eye.

Pathophysiology

The pupillary light reflex depends mainly on:

• Retinal ganglion cells
• Their axons within the optic nerve
• Pretectal projections

A unilateral or asymmetric lesion reduces the neural signal generated by illumination of that eye.

When the light swings from the normal eye to the affected eye:

Both pupils appear to dilate because afferent input has decreased.

RAPD vs Efferent Pupillary Defect

An isolated efferent problem such as:

• CN III palsy
• Pharmacologic mydriasis
• Iris sphincter damage

does not itself create an RAPD.

This is because the swinging flashlight test compares:

Afferent input from each eye

rather than the ability of one pupil to constrict.

Anisocoria and RAPD

An RAPD does not require anisocoria.

Many patients with an RAPD have:

Equal pupil sizes at rest.

Likewise:

Anisocoria does not imply an RAPD.

Major Causes

The most common causes are:

• Optic neuropathy
• Severe asymmetric retinal disease

Optic Nerve Causes

Optic nerve disease is the classic cause.

Examples include:

• Optic neuritis
• NAION
• Arteritic anterior ischemic optic neuropathy
• Compressive optic neuropathy
• Traumatic optic neuropathy
• Infiltrative optic neuropathy
• Radiation optic neuropathy
• Advanced asymmetric glaucoma
• Toxic/nutritional optic neuropathy if asymmetric
• Hereditary optic neuropathy during asymmetric stages

Optic Neuritis

Typical findings include:

• Acute/subacute monocular visual loss
• Reduced color vision
• Contrast loss
• Pain with eye movement
• Central or cecocentral field defect
• RAPD if unilateral or asymmetric

The optic disc may initially be:

• Normal
• Mildly swollen

Ischemic Optic Neuropathy

Both:

• NAION
• AAION

typically produce an RAPD when unilateral.

In an older patient with:

• Sudden visual loss
• RAPD
• Pale disc edema
• GCA symptoms

arteritic ischemic optic neuropathy must be considered urgently.

Compressive Optic Neuropathy

A slowly progressive RAPD may occur with:

• Optic nerve sheath meningioma
• Orbital mass
• Pituitary/parasellar tumor
• Intracranial mass
• Thyroid orbitopathy with apical compression

Associated findings may include:

• Dyschromatopsia
• Field loss
• Optic pallor
• Proptosis
• Motility abnormalities

Glaucoma

Glaucoma can produce an RAPD when damage is:

Significantly asymmetric

The RAPD generally corresponds to the eye with greater:

• RNFL loss
• Visual field damage
• Ganglion cell loss

Early symmetric glaucoma usually does not produce one.

Retinal Causes

Retinal disease must generally be:

Extensive or markedly asymmetric

to produce an RAPD.

Important examples include:

• Central retinal artery occlusion
• Large branch retinal artery occlusion
• Extensive retinal detachment
• Severe retinal ischemia
• Advanced asymmetric retinal dystrophy
• Severe asymmetric retinal vascular occlusion

Central Retinal Artery Occlusion

CRAO commonly produces a:

Dense RAPD

because a large proportion of the inner retinal circulation and ganglion cell function is abruptly lost.

This may be present even before classic funduscopic findings are fully developed.

Retinal Detachment

A large retinal detachment can produce an RAPD, particularly if:

• The macula is detached
• A large retinal area is involved

The magnitude generally reflects:

Extent of functioning retinal loss.

Macular Disease

Isolated macular disease usually produces:

• Reduced central acuity
• Metamorphopsia
• Central scotoma

but often little or no RAPD unless disease is:

Severe and markedly asymmetric.

This can help distinguish some maculopathies from optic neuropathy.

Chiasmal Disease

Chiasmal lesions usually affect both eyes, but an RAPD may occur when damage is:

Asymmetric

Examples include:

• Pituitary mass
• Craniopharyngioma
• Other parasellar lesions

Visual fields are especially important for localization.

Optic Tract Lesions

An optic tract lesion may produce a:

Contralateral RAPD

because the contralateral eye contributes more crossed nasal retinal fibers to the affected tract.

This is sometimes called:

Wernicke hemianopic pupil

although the full classic phenomenon is rarely tested clinically.

Associated visual field finding:

Contralateral homonymous hemianopia

Bilateral Disease

No RAPD may be present when disease is bilaterally symmetric, including:

• Bilateral optic neuritis
• Bilateral advanced glaucoma
• Bilateral toxic optic neuropathy
• Bilateral hereditary optic neuropathy

Thus:

Absence of RAPD does not mean the afferent visual pathways are normal.

Media Opacity

A major examination pearl:

Typical cataract does not produce an RAPD in the cataractous eye.

This is because enough light generally reaches the retina to generate the pupillary response.

Dense Cataract Nuance

Very dense asymmetric media opacity can alter pupillary responses in complex ways, but an RAPD attributable simply to ordinary cataract should be viewed with caution.

If a patient with cataract has an RAPD in that eye, look for:

• Optic neuropathy
• Retinal disease
• Advanced glaucoma

rather than assuming the cataract is responsible.

Vitreous Hemorrhage

Very dense vitreous hemorrhage can reduce retinal illumination enough to produce or contribute to an RAPD, particularly when extremely extensive.

However, an unexpectedly large RAPD should prompt consideration of:

• Retinal detachment
• Retinal ischemia
• Optic nerve disease

behind the media opacity.

Amblyopia

Amblyopia generally does not produce a large RAPD.

A small RAPD may occasionally be detected in marked asymmetric amblyopia, but a substantial RAPD should prompt investigation for:

Organic afferent disease.

Clinical History

Ask about:

• Sudden or progressive vision loss
• Color desaturation
• Brightness difference between eyes
• Visual field loss
• Pain with eye movement
• Headache
• Temporal/scalp tenderness
• Jaw claudication
• Trauma
• Previous malignancy
• Radiation therapy
• Neurologic symptoms

Brightness Desaturation

Patients with optic neuropathy may report that light appears:

Dimmer in the affected eye

This can be tested informally by comparing a bright target or light between the two eyes.

Marked brightness asymmetry supports:

Afferent pathway dysfunction

but is subjective.

Red Desaturation

A red target may appear:

• Less saturated
• Darker
• Washed out

in an eye with optic neuropathy.

This is especially useful when visual acuity loss is mild.

Swinging Flashlight Test

This is the standard bedside examination for RAPD.

Examination Technique

The patient should:

• Fixate on a distant target
• Be examined in relatively dim ambient illumination

Use a:

Bright, focused light source

Step 1

Illuminate one eye for approximately:

2–3 seconds

and observe:

• Direct constriction
• Consensual constriction

Step 2

Quickly swing the light to the fellow eye.

Hold for another:

2–3 seconds

and compare the response.

Repeat several times.

Normal Response

When light is moved between two normal eyes:

• Both pupils remain similarly constricted
• There is no systematic relative dilation

Minor hippus may occur.

Positive RAPD

If light is moved from the better eye to the affected eye:

Both pupils constrict less or relatively dilate

because the afferent signal has fallen.

The apparent dilation is often called:

Pupillary escape

although the essential finding is a relative reduction in constriction.

Critical Examination Pearl

The affected pupil does not uniquely dilate.

Because the light reflex projects bilaterally:

Both pupils show the same consensual response to reduced afferent input.

This is why an RAPD can often still be recognized even if one pupil has an efferent abnormality, by observing the fellow functioning pupil.

Avoiding False Results

Common causes of misleading testing include:

• Moving the light too slowly
• Unequal illumination distance
• Shining light obliquely rather than directly
• Allowing accommodation by near fixation
• Severe hippus
• Not waiting long enough in each eye
• Comparing pupils rather than comparing the response to stimulation of each eye

Neutral Density Filter Testing

RAPD can be quantified using:

Neutral density filters

placed over the better eye until pupillary responses become symmetric.

The strength is expressed in:

Log units

This is more objective than simple +1 to +4 grading.

Clinical RAPD Grading

A qualitative system may describe:

• Trace
• 1+
• 2+
• 3+
• 4+

However:

Clinical grading is examiner-dependent and not fully standardized.

Neutral-density quantification is preferable when precise measurement is required.

Automated Pupillometry

Infrared pupillometry can objectively measure:

• Constriction amplitude
• Velocity
• Latency
• Inter-eye differences

It is increasingly useful in:

• Research
• Neuro-ophthalmic assessment

but is not required for routine diagnosis.

Visual Acuity

Measure:

• Distance acuity
• Near acuity

Remember:

Visual acuity does not determine whether an RAPD is present.

A patient with severe macular blur may have no RAPD, whereas one with optic neuropathy and 20/20 acuity may have one.

Color Vision

Test:

• Ishihara plates
• Red desaturation
• Other formal color tests

Dyschromatopsia is especially suggestive of:

Optic nerve dysfunction.

Visual Fields

Automated perimetry helps:

• Quantify functional loss
• Localize disease

Patterns may include:

• Central scotoma
• Arcuate defect
• Altitudinal defect
• Bitemporal hemianopia
• Homonymous hemianopia

OCT

OCT should assess:

• Peripapillary RNFL
• Macular GCIPL/GCC

It can identify structural evidence of:

• Optic neuropathy
• Glaucoma
• Chiasmal disease patterns

However, OCT may be normal early in:

• Acute optic neuritis
• Acute posterior optic neuropathy

Dilated Fundus Examination

Look for:

• Retinal artery occlusion
• Retinal detachment
• Retinal ischemia
• Optic disc edema
• Optic atrophy
• Advanced glaucoma
• Retinal dystrophy

Neuroimaging

An unexplained RAPD with no adequate ocular explanation should prompt investigation for:

Optic nerve or intracranial disease

when clinically appropriate.

MRI

For suspected optic neuropathy or compressive disease, the preferred examination is usually:

MRI brain and orbits with contrast and fat-suppressed orbital sequences

depending on clinical context.

This is especially important for:

• Optic neuritis
• Compressive optic neuropathy
• Infiltrative disease
• Chiasmal lesions

Important Modern Correction

MRI is not automatically mandatory for every RAPD.

If the cause is already clearly established by ocular examination—for example:

• CRAO
• Large retinal detachment
• Advanced asymmetric glaucoma

neuroimaging may not be necessary solely because an RAPD is present.

Imaging is most important when the defect is:

• Unexplained
• Suggestive of optic neuropathy
• Associated with neurologic signs

Giant Cell Arteritis

In an older patient with acute visual loss and RAPD, especially with:

• New headache
• Scalp tenderness
• Jaw claudication
• Constitutional symptoms
• Pale swollen optic disc

consider:

Giant cell arteritis

urgently.

Tests include:

• ESR
• CRP
• Platelet count

Treatment should not be delayed when clinical suspicion is high.

Pediatric Considerations

In preverbal children, an RAPD can provide valuable objective evidence of:

Asymmetric retinal or optic nerve dysfunction

Potential causes include:

• Optic nerve hypoplasia
• Retinal detachment
• Optic pathway tumor
• Traumatic optic neuropathy
• Severe asymmetric retinal disease

A definite RAPD in a child requires explanation.

Differential Diagnosis

The major categories are:

• Optic neuropathy
• Severe asymmetric retinal disease
• Asymmetric chiasmal disease
• Optic tract lesion
• Severe asymmetric glaucoma

Apparent abnormalities from:

• Hippus
• Unequal illumination
• Efferent pupillary defects

should not be mistaken for true RAPD.

Treatment

There is:

No treatment for the RAPD itself.

Treatment is directed at the underlying disorder.

Examples:

• Optic neuritis → appropriate neurologic/neuro-ophthalmic management
• GCA → immediate systemic corticosteroid therapy
• CRAO → acute retinal/stroke evaluation
• Retinal detachment → retinal repair
• Compression → treat mass
• Glaucoma → lower IOP

Follow-Up

Follow-up depends entirely on the underlying disease.

Serial RAPD assessment can help monitor:

• Progression
• Inter-eye asymmetry

but is generally less precise than:

• Visual fields
• OCT
• Visual acuity
• Color testing

for longitudinal monitoring.

Prognosis

An RAPD itself has no independent prognosis.

Outcome depends on:

• Etiology
• Severity
• Duration
• Reversibility of underlying afferent injury

The RAPD may decrease if function improves, but can persist despite partial recovery.

Ophthalmology Pearls

• An RAPD is an objective sign of asymmetric afferent visual pathway dysfunction and always requires an explanation.
• The most common causes are optic neuropathy and severe asymmetric retinal disease.
• On the swinging flashlight test, moving the light from the better eye to the affected eye causes both pupils to constrict less or relatively dilate.
• An RAPD is a relative sign; severe bilateral symmetric optic neuropathy may produce no RAPD.
• Anisocoria is not required for an RAPD, and anisocoria alone does not imply an afferent defect.
• Isolated efferent pupillary abnormalities do not cause RAPD.
• Optic neuritis, ischemic optic neuropathy, compression, traumatic optic neuropathy, and markedly asymmetric glaucoma are classic optic nerve causes.
• CRAO commonly produces a dense RAPD, while a large retinal detachment can also produce one.
• Isolated macular disease usually produces little or no RAPD unless retinal dysfunction is extensive.
• Ordinary cataract does not explain an RAPD in the cataractous eye; look for retinal or optic nerve disease.
• Dense vitreous hemorrhage may affect the response, but a substantial RAPD should prompt evaluation for underlying retinal ischemia, detachment, or optic neuropathy.
• A small RAPD may occasionally occur in severe amblyopia, but a large defect should be considered organic until proven otherwise.
• Brightness and red desaturation are useful bedside signs of optic neuropathy.
• Neutral density filters provide a more objective RAPD measurement than qualitative +1 to +4 grading.
• An unexplained RAPD with a normal retinal examination should raise strong suspicion for optic nerve disease and often warrants MRI of the brain/orbits with dedicated contrast-enhanced fat-suppressed sequences.
• MRI is not automatically necessary when the ocular cause is already obvious, such as CRAO, large retinal detachment, or advanced asymmetric glaucoma.
• In older patients with acute visual loss and RAPD, always consider giant cell arteritis when the history or disc appearance is compatible.

Ophthalmology – Reactive Arthritis (Reiter Syndrome)

Basics

Description

Reactive arthritis (ReA) is an inflammatory seronegative spondyloarthritis that develops after certain genitourinary or gastrointestinal infections.

The traditional term:

Reiter syndrome

is now generally avoided; reactive arthritis is the preferred terminology.

The classic triad is:

• Arthritis
• Urethritis/cervicitis
• Conjunctivitis

However:

Most patients do not present with the complete triad.

Ocular involvement may include:

• Conjunctivitis
• Acute nongranulomatous anterior uveitis
• Episcleritis
• Rare keratitis or posterior-segment inflammation

The ophthalmically important complication is:

Recurrent anterior uveitis, which may threaten vision if inadequately treated.

Classification

Reactive arthritis belongs to the:

Spondyloarthritis spectrum

along with:

• Ankylosing spondylitis / axial spondyloarthritis
• Psoriatic arthritis
• Inflammatory bowel disease-associated arthritis

These disorders share associations with:

• HLA-B27
• Enthesitis
• Sacroiliitis
• Acute anterior uveitis

Epidemiology

Reactive arthritis typically affects:

• Adolescents
• Young adults

Historically, sexually acquired ReA has been reported more often in men.

The true incidence varies considerably according to:

• Population
• Triggering organism
• Diagnostic criteria
• Geographic region

HLA-B27

HLA-B27 is an important susceptibility and prognostic factor, but it is not required for diagnosis.

The frequency of HLA-B27 positivity varies substantially among cohorts and is generally lower than older estimates of 70–90%.

HLA-B27 positivity is associated with:

• More severe disease
• Sacroiliitis
• Recurrent disease
• Higher likelihood of acute anterior uveitis
• Greater risk of chronic spondyloarthritis phenotype

Important Diagnostic Principle

A positive HLA-B27 test:

Does not diagnose reactive arthritis.

A negative result:

Does not exclude it.

Testing is most useful when:

• Uveitis is recurrent
• Axial symptoms are present
• Spondyloarthritis is suspected
• Prognostic information is needed

Etiology

Reactive arthritis usually develops after infection with certain organisms.

The most important are:

Genitourinary

• Chlamydia trachomatis

Enteric

• Salmonella
• Shigella
• Campylobacter
• Yersinia

Other infectious triggers have been reported, but associations are less consistent.

Timing

Symptoms typically begin:

About 1–4 weeks after the triggering infection

The original infection may have:

• Resolved
• Been mild
• Gone unnoticed

by the time arthritis or uveitis appears.

Pathophysiology

Reactive arthritis is not usually caused by active organisms invading the joint.

Instead, it reflects:

Immune-mediated inflammation triggered by infection in a genetically susceptible host

Possible mechanisms include:

• Persistent bacterial antigens
• Innate immune activation
• Abnormal adaptive immune response
• HLA-B27-associated immune dysregulation

Sterile Arthritis

Joint inflammation is usually:

Culture-negative

hence the term:

Reactive arthritis

rather than septic arthritis.

However, septic arthritis must still be excluded when clinically suspected.

Chlamydia-Associated Disease

In Chlamydia-associated ReA, bacterial components may persist within host cells and contribute to prolonged immune activation.

Chlamydia remains one of the most important identifiable triggers of:

Sexually acquired reactive arthritis.

Enteric Reactive Arthritis

Reactive arthritis can follow gastroenteritis caused by:

• Salmonella
• Shigella
• Campylobacter
• Yersinia

The arthritis often begins after gastrointestinal symptoms have already improved.

Risk Factors

Important risk factors include:

• Recent Chlamydia infection
• Recent bacterial gastroenteritis
• HLA-B27
• Prior reactive arthritis
• Features of underlying spondyloarthritis

HIV

Reactive arthritis can occur in people living with HIV.

However, the relationship is complex because:

• Spondyloarthritis phenotypes overlap
• Infection patterns differ
• Effective antiretroviral therapy has altered epidemiology

HIV testing should be performed when clinically indicated, particularly in patients with:

• Sexually transmitted infection risk
• Unexplained systemic inflammatory disease

Systemic Clinical Features

Reactive arthritis typically causes:

Acute asymmetric oligoarthritis

predominantly affecting the:

• Knees
• Ankles
• Feet

Enthesitis

Inflammation at tendon or ligament insertion sites is characteristic.

Common sites include:

• Achilles tendon
• Plantar fascia

This may produce:

• Heel pain
• Achilles tenderness

Dactylitis

Some patients develop:

Dactylitis

or “sausage digit” swelling.

Axial Disease

Possible features include:

• Sacroiliitis
• Inflammatory back pain

Axial involvement is more likely in:

• HLA-B27-positive
• Recurrent/chronic disease

Genitourinary Manifestations

Symptoms may include:

• Dysuria
• Urethral discharge
• Urinary frequency
• Cervicitis

However, Chlamydia infection may be:

Asymptomatic

especially in women.

Mucocutaneous Findings

Characteristic findings include:

• Circinate balanitis
• Painless oral ulcers
• Keratoderma blennorrhagicum

Keratoderma Blennorrhagicum

This consists of:

• Hyperkeratotic
• Psoriasiform
• Sometimes pustular

lesions, commonly involving:

• Soles
• Palms

It may resemble psoriasis.

Ocular Manifestations

Ocular involvement is common enough to be clinically important.

The major manifestations are:

• Conjunctivitis
• Acute anterior uveitis

Less commonly:

• Episcleritis
• Scleritis
• Keratitis
• Posterior-segment inflammation

Conjunctivitis

Conjunctivitis often appears:

Early in the systemic illness

and may be:

• Bilateral
• Mild
• Self-limited

Symptoms include:

• Redness
• Irritation
• Tearing
• Mild discharge

It may resolve before the patient presents with arthritis.

Conjunctivitis Examination

Typical findings include:

• Diffuse conjunctival injection
• Mild papillary or follicular response
• Watery or mucoid discharge

Vision is usually:

Normal

unless another ocular complication is present.

Treatment of Conjunctivitis

Most uncomplicated conjunctivitis requires:

• Preservative-free lubricants
• Cold compresses

Topical antibiotics are not routinely required unless:

• Bacterial conjunctivitis is suspected separately

Acute Anterior Uveitis

The most important ocular manifestation is:

Acute nongranulomatous anterior uveitis

It resembles HLA-B27-associated uveitis seen in other spondyloarthropathies.

Typical Uveitis Pattern

Features include:

• Acute onset
• Usually unilateral at a given episode
• Pain
• Photophobia
• Ciliary injection
• Blurred vision
• Anterior chamber cells and flare

Disease may alternate between eyes over recurrent episodes.

Severe HLA-B27-Type Uveitis

More severe attacks may cause:

• Fibrin
• Hypopyon
• Posterior synechiae
• Marked anterior chamber reaction

A hypopyon in this setting is typically:

Sterile inflammatory material

but infectious endophthalmitis must be excluded when the clinical context is atypical.

Posterior Synechiae

Inflammation may cause adhesions between:

• Iris
• Anterior lens capsule

called:

Posterior synechiae

Cycloplegic/mydriatic therapy helps prevent or break early synechiae.

Uveitic Complications

Recurrent or poorly controlled inflammation may cause:

• Posterior synechiae
• Cataract
• Ocular hypertension
• Secondary glaucoma
• Cystoid macular edema
• Epiretinal membrane
• Vision loss

Keratitis

Corneal involvement is uncommon.

Reported findings include:

• Superficial punctate keratitis
• Peripheral inflammatory keratitis

Persistent focal ulceration should prompt investigation for:

• Infection
• Herpes simplex
• Other immune-mediated corneal disease

rather than automatically attributing it to reactive arthritis.

Diagnosis

Reactive arthritis is primarily a:

Clinical diagnosis

based on:

• Characteristic arthritis
• Compatible preceding infection
• Extra-articular findings

There is:

No single diagnostic laboratory test.

History

Ask about infection within the preceding several weeks.

Genitourinary History

Ask about:

• Dysuria
• Urethral/cervical discharge
• New sexual partner
• Known STI exposure

Gastrointestinal History

Ask about:

• Diarrhea
• Abdominal pain
• Foodborne illness
• Recent travel
• Similar illness among contacts

Musculoskeletal History

Ask about:

• Asymmetric joint swelling
• Knee or ankle pain
• Heel pain
• Morning stiffness
• Low back pain
• Buttock pain

Ophthalmic History

Ask about:

• Red eye
• Photophobia
• Eye pain
• Blurred vision
• Previous uveitis
• Alternating attacks between eyes

A patient with:

Pain + photophobia + reduced vision

requires assessment for uveitis rather than assuming simple conjunctivitis.

Physical Examination

Systemic examination should look for:

• Asymmetric oligoarthritis
• Enthesitis
• Dactylitis
• Sacroiliac tenderness
• Circinate balanitis
• Oral ulcers
• Keratoderma

Ophthalmic Examination

Perform:

• Visual acuity
• Pupils
• Slit-lamp examination
• IOP
• Dilated fundus examination when uveitis is present

Look specifically for:

• Anterior chamber cells
• Flare
• Fibrin
• Hypopyon
• Posterior synechiae
• Macular edema

Laboratory Evaluation

Tests should be targeted according to the suspected trigger and differential diagnosis.

Possible studies include:

• CBC
• CRP
• ESR

These may demonstrate inflammation but are:

Nonspecific.

Chlamydia Testing

The preferred test for suspected genital Chlamydia is:

Nucleic acid amplification testing (NAAT)

using:

• First-catch urine
• Vaginal/cervical swab
• Urethral specimen as appropriate

Gonorrhea Testing

Because sexually transmitted infections may coexist, testing commonly includes:

Neisseria gonorrhoeae NAAT

when sexually acquired disease is suspected.

Stool Testing

If gastrointestinal symptoms are:

• Recent
• Ongoing

stool culture or multiplex PCR may identify an enteric pathogen.

However, by the time arthritis appears, the gastrointestinal infection may already have cleared, so:

A negative stool test does not exclude post-enteric reactive arthritis.

HLA-B27 Testing

Consider HLA-B27 testing when:

• Recurrent anterior uveitis occurs
• Axial symptoms are present
• Diagnosis within the spondyloarthritis spectrum is uncertain
• Prognostic information is useful

It is not a screening test for every red eye or arthritis episode.

HIV and STI Screening

Depending on risk profile, consider:

• HIV testing
• Syphilis testing
• Other STI testing

particularly when Chlamydia-associated reactive arthritis is suspected.

Joint Aspiration

Synovial fluid analysis is important when the differential includes:

• Septic arthritis
• Crystal arthritis

Reactive arthritis usually shows:

• Inflammatory fluid
• Negative bacterial culture

Imaging

Imaging is not required for every acute case.

Depending on symptoms, studies may include:

• Plain radiographs
• Ultrasound
• MRI of sacroiliac joints

MRI is particularly useful when evaluating:

Early inflammatory sacroiliitis.

Differential Diagnosis

Important differentials include:

• Axial spondyloarthritis
• Psoriatic arthritis
• IBD-associated arthritis
• Septic arthritis
• Disseminated gonococcal infection
• Rheumatoid arthritis
• Crystal arthritis
• Lyme disease
• Sarcoidosis
• Behçet disease
• Systemic lupus erythematosus

Ophthalmic Differential Diagnosis

For acute red eye, consider:

• Conjunctivitis
• HLA-B27-associated anterior uveitis from another spondyloarthritis
• HSV/VZV anterior uveitis
• Syphilitic uveitis
• Sarcoid uveitis
• Behçet disease
• Infectious keratitis
• Scleritis

Treatment Principles

Treatment has three components:

1. Treat an active triggering infection when present
2. Control musculoskeletal inflammation
3. Treat ocular inflammation promptly

Antibiotic Treatment – Chlamydia

If active Chlamydia trachomatis infection is identified:

Treat according to current STI guidelines.

The goals are to:

• Eradicate infection
• Prevent transmission
• Prevent reinfection

Sexual partners also require:

• Evaluation
• Appropriate treatment

Antibiotics and Arthritis

An important distinction:

Antibiotics treat the infection, but they do not reliably terminate established reactive arthritis.

For post-enteric reactive arthritis after the infection has resolved:

Routine prolonged antibiotics are not recommended.

Chronic Chlamydia-Associated ReA

Prolonged combination antibiotic regimens have been investigated in selected chronic Chlamydia-associated disease, but this remains a:

Specialist and nonroutine strategy

rather than standard management for all reactive arthritis.

Musculoskeletal Treatment

NSAIDs

First-line treatment for acute arthritis is usually:

NSAID therapy

assuming no contraindication.

Examples include:

• Naproxen
• Ibuprofen
• Celecoxib
• Other appropriate NSAIDs

There is no requirement to use indomethacin specifically.

Local Corticosteroids

For persistent inflammation involving one or a few joints:

Intra-articular corticosteroid injection

can be effective after septic arthritis has been excluded.

Systemic Corticosteroids

A short systemic corticosteroid course may be considered for:

• Severe polyarthritis
• Major extra-articular inflammation

when NSAIDs are inadequate.

DMARD Therapy

Persistent or chronic arthritis may require:

• Sulfasalazine
• Methotrexate

under rheumatology supervision.

Other conventional immunosuppressants are individualized rather than routine first choices.

Biologic Therapy

For chronic refractory spondyloarthritis-like disease, biologic therapy may be considered.

Options include:

• TNF inhibitors

depending on:

• Axial vs peripheral phenotype
• Previous treatment
• Comorbidities

This should be managed by rheumatology.

Treatment of Anterior Uveitis

The standard initial ocular treatment is:

Topical corticosteroid + cycloplegic/mydriatic

Topical Corticosteroid

For significant anterior chamber inflammation, commonly:

Prednisolone acetate 1%

is used frequently initially.

Severe disease may require dosing:

• Hourly while awake

followed by a:

Slow taper according to inflammatory response.

The taper should be based on:

• Anterior chamber cell
• Flare
• Symptoms

rather than a fixed schedule.

Cycloplegia

Options include:

• Cyclopentolate
• Homatropine
• Atropine in severe cases

Cycloplegics:

• Relieve ciliary spasm
• Reduce pain
• Prevent posterior synechiae
• Help break early synechiae

Severe or Refractory Uveitis

If topical therapy is insufficient, treatment may escalate to:

• Periocular corticosteroid
• Systemic corticosteroid
• Steroid-sparing immunomodulatory therapy

depending on:

• Severity
• Recurrence
• Bilateral involvement
• Posterior involvement

Recurrent Uveitis

Frequent recurrent attacks may require coordination between:

• Ophthalmology
• Rheumatology

Systemic therapy used for the underlying spondyloarthritis can sometimes reduce ocular recurrences.

Biologic Therapy and Uveitis

When biologic treatment is required for associated spondyloarthritis, certain monoclonal anti-TNF agents such as:

• Adalimumab
• Infliximab

have evidence for reducing recurrent anterior uveitis.

Not all TNF inhibitors have equivalent efficacy for ocular inflammation.

Monitoring During Uveitis Treatment

Monitor:

• Visual acuity
• Anterior chamber inflammation
• IOP
• Posterior synechiae
• Lens clarity
• Macula

Long-term topical corticosteroids can cause:

• Cataract
• Steroid-induced ocular hypertension/glaucoma

Prognosis

Reactive arthritis is often:

Self-limited

with substantial improvement over:

Several months

However, some patients develop:

• Recurrences
• Persistent arthritis
• Chronic spondyloarthritis

Chronic Disease Risk

Chronicity is more likely with:

• HLA-B27 positivity
• Severe initial disease
• Recurrent attacks
• Sacroiliitis
• Persistent inflammatory symptoms

Ocular Prognosis

Simple conjunctivitis usually has:

Excellent prognosis

Anterior uveitis also generally responds well when treated promptly.

Poorer outcomes are associated with:

• Repeated severe attacks
• Delayed treatment
• Cystoid macular edema
• Cataract
• Secondary glaucoma

Referral

Ophthalmology

Urgent assessment for:

• Photophobia
• Eye pain
• Reduced vision
• Suspected anterior uveitis

Rheumatology

Appropriate for:

• Significant arthritis
• Persistent symptoms
• Sacroiliitis
• Recurrent uveitis
• Suspected chronic spondyloarthritis

Sexual Health / Primary Care

For:

• Chlamydia or gonorrhea testing
• STI treatment
• Partner management

Ophthalmology Pearls

• Reactive arthritis is the preferred term; “Reiter syndrome” is now largely historical terminology.
• The classic triad is arthritis + urethritis/cervicitis + conjunctivitis, but the complete triad is uncommon.
• Major infectious triggers are Chlamydia trachomatis and the enteric organisms Salmonella, Shigella, Campylobacter, and Yersinia.
• Symptoms typically begin 1–4 weeks after the triggering infection, which may already have resolved.
• HLA-B27 is neither required nor diagnostic; it is most useful as a susceptibility and prognostic marker.
• The typical arthritis is asymmetric oligoarthritis of the lower extremities, often accompanied by enthesitis.
• Characteristic systemic findings include circinate balanitis, painless oral ulcers, and keratoderma blennorrhagicum.
• Conjunctivitis is usually an early, mild, self-limited manifestation and may have resolved by the time arthritis is diagnosed.
• The major vision-threatening manifestation is acute nongranulomatous anterior uveitis.
• Reactive-arthritis uveitis usually resembles other HLA-B27 anterior uveitis: acute, painful, photophobic, often unilateral, and sometimes fibrinous or hypopyon-forming.
• Pain, photophobia, and reduced vision in a patient thought to have “conjunctivitis” should prompt slit-lamp examination for anterior uveitis.
• First-line treatment of anterior uveitis is intensive topical corticosteroid plus cycloplegia, with treatment tapered according to clinical response.
• Monitor uveitis patients for posterior synechiae, cataract, steroid-induced IOP elevation, glaucoma, and cystoid macular edema.
• NAAT is preferred for Chlamydia and gonorrhea testing when sexually acquired disease is suspected.
• Treat active Chlamydia infection and sexual partners appropriately, but antibiotics do not reliably cure established reactive arthritis.
• Routine prolonged antibiotics are not recommended for post-enteric reactive arthritis once the gastrointestinal infection has resolved.
• Persistent arthritis may require NSAIDs, intra-articular steroids, sulfasalazine or methotrexate, and occasionally biologic therapy.
• In patients requiring systemic biologic therapy who also have recurrent uveitis, monoclonal anti-TNF agents such as adalimumab or infliximab may reduce ocular recurrences.
• Most patients improve, but a subset develops recurrent uveitis or chronic spondyloarthritis, making coordinated ophthalmology–rheumatology follow-up important.

Classification Reactive arthritis belongs to the: Spondyloarthritis spectrum along with:  Ankylosing spondylitis / axial spondyloarthritis Psoriatic arthritis Inflammatory bowel disease-associated arthritis  These disorders share associations with:  HLA-B27 Enthesitis Sacroiliitis Acute anterior uveitis

Epidemiology Reactive arthritis typically affects:  Adolescents Young adults  Historically, sexually acquired ReA has been reported more often in men. The true incidence varies considerably according to:  Population Triggering organism Diagnostic criteria Geographic region

HLA-B27 HLA-B27 is an important susceptibility and prognostic factor, but it is not required for diagnosis. The frequency of HLA-B27 positivity varies substantially among cohorts and is generally lower than older estimates of 70–90%. HLA-B27 positivity is associated with:  More severe disease Sacroiliitis Recurrent disease Higher likelihood of acute anterior uveitis Greater risk of chronic spondyloarthritis phenotype

Important Diagnostic Principle A positive HLA-B27 test: Does not diagnose reactive arthritis. A negative result: Does not exclude it. Testing is most useful when:  Uveitis is recurrent Axial symptoms are present Spondyloarthritis is suspected Prognostic information is needed

Etiology Reactive arthritis usually develops after infection with certain organisms. The most important are: Genitourinary  Chlamydia trachomatis  Enteric  Salmonella Shigella Campylobacter Yersinia  Other infectious triggers have been reported, but associations are less consistent.

Timing Symptoms typically begin: About 1–4 weeks after the triggering infection The original infection may have:  Resolved Been mild Gone unnoticed  by the time arthritis or uveitis appears.

Pathophysiology Reactive arthritis is not usually caused by active organisms invading the joint. Instead, it reflects: Immune-mediated inflammation triggered by infection in a genetically susceptible host Possible mechanisms include:  Persistent bacterial antigens Innate immune activation Abnormal adaptive immune response HLA-B27-associated immune dysregulation

Sterile Arthritis Joint inflammation is usually: Culture-negative hence the term: Reactive arthritis rather than septic arthritis. However, septic arthritis must still be excluded when clinically suspected.

Chlamydia-Associated Disease In Chlamydia-associated ReA, bacterial components may persist within host cells and contribute to prolonged immune activation. Chlamydia remains one of the most important identifiable triggers of: Sexually acquired reactive arthritis.

Enteric Reactive Arthritis Reactive arthritis can follow gastroenteritis caused by:  Salmonella Shigella Campylobacter Yersinia  The arthritis often begins after gastrointestinal symptoms have already improved.

Risk Factors Important risk factors include:  Recent Chlamydia infection Recent bacterial gastroenteritis HLA-B27 Prior reactive arthritis Features of underlying spondyloarthritis

HIV Reactive arthritis can occur in people living with HIV. However, the relationship is complex because:  Spondyloarthritis phenotypes overlap Infection patterns differ Effective antiretroviral therapy has altered epidemiology  HIV testing should be performed when clinically indicated, particularly in patients with:  Sexually transmitted infection risk Unexplained systemic inflammatory disease

Systemic Clinical Features Reactive arthritis typically causes: Acute asymmetric oligoarthritis predominantly affecting the:  Knees Ankles Feet

Enthesitis Inflammation at tendon or ligament insertion sites is characteristic. Common sites include:  Achilles tendon Plantar fascia  This may produce:  Heel pain Achilles tenderness

Dactylitis Some patients develop: Dactylitis or “sausage digit” swelling.

Axial Disease Possible features include:  Sacroiliitis Inflammatory back pain  Axial involvement is more likely in:  HLA-B27-positive Recurrent/chronic disease

Genitourinary Manifestations Symptoms may include:  Dysuria Urethral discharge Urinary frequency Cervicitis  However, Chlamydia infection may be: Asymptomatic especially in women.

Mucocutaneous Findings Characteristic findings include:  Circinate balanitis Painless oral ulcers Keratoderma blennorrhagicum

Keratoderma Blennorrhagicum This consists of:  Hyperkeratotic Psoriasiform Sometimes pustular  lesions, commonly involving:  Soles Palms  It may resemble psoriasis.

Ocular Manifestations Ocular involvement is common enough to be clinically important. The major manifestations are:  Conjunctivitis Acute anterior uveitis  Less commonly:  Episcleritis Scleritis Keratitis Posterior-segment inflammation

Conjunctivitis Conjunctivitis often appears: Early in the systemic illness and may be:  Bilateral Mild Self-limited  Symptoms include:  Redness Irritation Tearing Mild discharge  It may resolve before the patient presents with arthritis.

Conjunctivitis Examination Typical findings include:  Diffuse conjunctival injection Mild papillary or follicular response Watery or mucoid discharge  Vision is usually: Normal unless another ocular complication is present.

Treatment of Conjunctivitis Most uncomplicated conjunctivitis requires:  Preservative-free lubricants Cold compresses  Topical antibiotics are not routinely required unless:  Bacterial conjunctivitis is suspected separately

Acute Anterior Uveitis The most important ocular manifestation is: Acute nongranulomatous anterior uveitis It resembles HLA-B27-associated uveitis seen in other spondyloarthropathies.

Typical Uveitis Pattern Features include:  Acute onset Usually unilateral at a given episode Pain Photophobia Ciliary injection Blurred vision Anterior chamber cells and flare  Disease may alternate between eyes over recurrent episodes.

Severe HLA-B27-Type Uveitis More severe attacks may cause:  Fibrin Hypopyon Posterior synechiae Marked anterior chamber reaction  A hypopyon in this setting is typically: Sterile inflammatory material but infectious endophthalmitis must be excluded when the clinical context is atypical.

Posterior Synechiae Inflammation may cause adhesions between:  Iris Anterior lens capsule  called: Posterior synechiae Cycloplegic/mydriatic therapy helps prevent or break early synechiae.

Uveitic Complications Recurrent or poorly controlled inflammation may cause:  Posterior synechiae Cataract Ocular hypertension Secondary glaucoma Cystoid macular edema Epiretinal membrane Vision loss

Keratitis Corneal involvement is uncommon. Reported findings include:  Superficial punctate keratitis Peripheral inflammatory keratitis  Persistent focal ulceration should prompt investigation for:  Infection Herpes simplex Other immune-mediated corneal disease  rather than automatically attributing it to reactive arthritis.

Diagnosis Reactive arthritis is primarily a: Clinical diagnosis based on:  Characteristic arthritis Compatible preceding infection Extra-articular findings  There is: No single diagnostic laboratory test.

History Ask about infection within the preceding several weeks. Genitourinary History Ask about:  Dysuria Urethral/cervical discharge New sexual partner Known STI exposure  Gastrointestinal History Ask about:  Diarrhea Abdominal pain Foodborne illness Recent travel Similar illness among contacts

Musculoskeletal History Ask about:  Asymmetric joint swelling Knee or ankle pain Heel pain Morning stiffness Low back pain Buttock pain

Ophthalmic History Ask about:  Red eye Photophobia Eye pain Blurred vision Previous uveitis Alternating attacks between eyes  A patient with: Pain + photophobia + reduced vision requires assessment for uveitis rather than assuming simple conjunctivitis.

Physical Examination Systemic examination should look for:  Asymmetric oligoarthritis Enthesitis Dactylitis Sacroiliac tenderness Circinate balanitis Oral ulcers Keratoderma

Ophthalmic Examination Perform:  Visual acuity Pupils Slit-lamp examination IOP Dilated fundus examination when uveitis is present  Look specifically for:  Anterior chamber cells Flare Fibrin Hypopyon Posterior synechiae Macular edema

Laboratory Evaluation Tests should be targeted according to the suspected trigger and differential diagnosis. Possible studies include:  CBC CRP ESR  These may demonstrate inflammation but are: Nonspecific.

Chlamydia Testing The preferred test for suspected genital Chlamydia is: Nucleic acid amplification testing (NAAT) using:  First-catch urine Vaginal/cervical swab Urethral specimen as appropriate

Gonorrhea Testing Because sexually transmitted infections may coexist, testing commonly includes: Neisseria gonorrhoeae NAAT when sexually acquired disease is suspected.

Stool Testing If gastrointestinal symptoms are:  Recent Ongoing  stool culture or multiplex PCR may identify an enteric pathogen. However, by the time arthritis appears, the gastrointestinal infection may already have cleared, so: A negative stool test does not exclude post-enteric reactive arthritis.

HLA-B27 Testing Consider HLA-B27 testing when:  Recurrent anterior uveitis occurs Axial symptoms are present Diagnosis within the spondyloarthritis spectrum is uncertain Prognostic information is useful  It is not a screening test for every red eye or arthritis episode.

HIV and STI Screening Depending on risk profile, consider:  HIV testing Syphilis testing Other STI testing  particularly when Chlamydia-associated reactive arthritis is suspected.

Joint Aspiration Synovial fluid analysis is important when the differential includes:  Septic arthritis Crystal arthritis  Reactive arthritis usually shows:  Inflammatory fluid Negative bacterial culture

Imaging Imaging is not required for every acute case. Depending on symptoms, studies may include:  Plain radiographs Ultrasound MRI of sacroiliac joints  MRI is particularly useful when evaluating: Early inflammatory sacroiliitis.

Differential Diagnosis Important differentials include:  Axial spondyloarthritis Psoriatic arthritis IBD-associated arthritis Septic arthritis Disseminated gonococcal infection Rheumatoid arthritis Crystal arthritis Lyme disease Sarcoidosis Behçet disease Systemic lupus erythematosus

Ophthalmic Differential Diagnosis For acute red eye, consider:  Conjunctivitis HLA-B27-associated anterior uveitis from another spondyloarthritis HSV/VZV anterior uveitis Syphilitic uveitis Sarcoid uveitis Behçet disease Infectious keratitis Scleritis

Treatment Principles Treatment has three components:  Treat an active triggering infection when present Control musculoskeletal inflammation Treat ocular inflammation promptly

Antibiotic Treatment – Chlamydia If active Chlamydia trachomatis infection is identified: Treat according to current STI guidelines. The goals are to:  Eradicate infection Prevent transmission Prevent reinfection  Sexual partners also require:  Evaluation Appropriate treatment

Antibiotics and Arthritis An important distinction: Antibiotics treat the infection, but they do not reliably terminate established reactive arthritis. For post-enteric reactive arthritis after the infection has resolved: Routine prolonged antibiotics are not recommended.

Chronic Chlamydia-Associated ReA Prolonged combination antibiotic regimens have been investigated in selected chronic Chlamydia-associated disease, but this remains a: Specialist and nonroutine strategy rather than standard management for all reactive arthritis.

Musculoskeletal Treatment NSAIDs First-line treatment for acute arthritis is usually: NSAID therapy assuming no contraindication. Examples include:  Naproxen Ibuprofen Celecoxib Other appropriate NSAIDs  There is no requirement to use indomethacin specifically.

Local Corticosteroids For persistent inflammation involving one or a few joints: Intra-articular corticosteroid injection can be effective after septic arthritis has been excluded.

Systemic Corticosteroids A short systemic corticosteroid course may be considered for:  Severe polyarthritis Major extra-articular inflammation  when NSAIDs are inadequate.

DMARD Therapy Persistent or chronic arthritis may require:  Sulfasalazine Methotrexate  under rheumatology supervision. Other conventional immunosuppressants are individualized rather than routine first choices.

Biologic Therapy For chronic refractory spondyloarthritis-like disease, biologic therapy may be considered. Options include:  TNF inhibitors  depending on:  Axial vs peripheral phenotype Previous treatment Comorbidities  This should be managed by rheumatology.

Treatment of Anterior Uveitis The standard initial ocular treatment is: Topical corticosteroid + cycloplegic/mydriatic

Topical Corticosteroid For significant anterior chamber inflammation, commonly: Prednisolone acetate 1% is used frequently initially. Severe disease may require dosing:  Hourly while awake  followed by a: Slow taper according to inflammatory response. The taper should be based on:  Anterior chamber cell Flare Symptoms  rather than a fixed schedule.

Cycloplegia Options include:  Cyclopentolate Homatropine Atropine in severe cases  Cycloplegics:  Relieve ciliary spasm Reduce pain Prevent posterior synechiae Help break early synechiae

Severe or Refractory Uveitis If topical therapy is insufficient, treatment may escalate to:  Periocular corticosteroid Systemic corticosteroid Steroid-sparing immunomodulatory therapy  depending on:  Severity Recurrence Bilateral involvement Posterior involvement

Recurrent Uveitis Frequent recurrent attacks may require coordination between:  Ophthalmology Rheumatology  Systemic therapy used for the underlying spondyloarthritis can sometimes reduce ocular recurrences.

Biologic Therapy and Uveitis When biologic treatment is required for associated spondyloarthritis, certain monoclonal anti-TNF agents such as:  Adalimumab Infliximab  have evidence for reducing recurrent anterior uveitis. Not all TNF inhibitors have equivalent efficacy for ocular inflammation.

Monitoring During Uveitis Treatment Monitor:  Visual acuity Anterior chamber inflammation IOP Posterior synechiae Lens clarity Macula  Long-term topical corticosteroids can cause:  Cataract Steroid-induced ocular hypertension/glaucoma

Prognosis Reactive arthritis is often: Self-limited with substantial improvement over: Several months However, some patients develop:  Recurrences Persistent arthritis Chronic spondyloarthritis

Chronic Disease Risk Chronicity is more likely with:  HLA-B27 positivity Severe initial disease Recurrent attacks Sacroiliitis Persistent inflammatory symptoms

Ocular Prognosis Simple conjunctivitis usually has: Excellent prognosis Anterior uveitis also generally responds well when treated promptly. Poorer outcomes are associated with:  Repeated severe attacks Delayed treatment Cystoid macular edema Cataract Secondary glaucoma

Referral Ophthalmology Urgent assessment for:  Photophobia Eye pain Reduced vision Suspected anterior uveitis  Rheumatology Appropriate for:  Significant arthritis Persistent symptoms Sacroiliitis Recurrent uveitis Suspected chronic spondyloarthritis  Sexual Health / Primary Care For:  Chlamydia or gonorrhea testing STI treatment Partner management

Ophthalmology Pearls  Reactive arthritis is the preferred term; “Reiter syndrome” is now largely historical terminology. The classic triad is arthritis + urethritis/cervicitis + conjunctivitis, but the complete triad is uncommon. Major infectious triggers are Chlamydia trachomatis and the enteric organisms Salmonella, Shigella, Campylobacter, and Yersinia. Symptoms typically begin 1–4 weeks after the triggering infection, which may already have resolved. HLA-B27 is neither required nor diagnostic; it is most useful as a susceptibility and prognostic marker. The typical arthritis is asymmetric oligoarthritis of the lower extremities, often accompanied by enthesitis. Characteristic systemic findings include circinate balanitis, painless oral ulcers, and keratoderma blennorrhagicum. Conjunctivitis is usually an early, mild, self-limited manifestation and may have resolved by the time arthritis is diagnosed. The major vision-threatening manifestation is acute nongranulomatous anterior uveitis. Reactive-arthritis uveitis usually resembles other HLA-B27 anterior uveitis: acute, painful, photophobic, often unilateral, and sometimes fibrinous or hypopyon-forming. Pain, photophobia, and reduced vision in a patient thought to have “conjunctivitis” should prompt slit-lamp examination for anterior uveitis. First-line treatment of anterior uveitis is intensive topical corticosteroid plus cycloplegia, with treatment tapered according to clinical response. Monitor uveitis patients for posterior synechiae, cataract, steroid-induced IOP elevation, glaucoma, and cystoid macular edema. NAAT is preferred for Chlamydia and gonorrhea testing when sexually acquired disease is suspected. Treat active Chlamydia infection and sexual partners appropriately, but antibiotics do not reliably cure established reactive arthritis. Routine prolonged antibiotics are not recommended for post-enteric reactive arthritis once the gastrointestinal infection has resolved. Persistent arthritis may require NSAIDs, intra-articular steroids, sulfasalazine or methotrexate, and occasionally biologic therapy. In patients requiring systemic biologic therapy who also have recurrent uveitis, monoclonal anti-TNF agents such as adalimumab or infliximab may reduce ocular recurrences. Most patients improve, but a subset develops recurrent uveitis or chronic spondyloarthritis, making coordinated ophthalmology–rheumatology follow-up important.

Ophthalmology – Reis-Bücklers Corneal Dystrophy

Basics

Description

Reis-Bücklers corneal dystrophy (RBCD) is a rare, bilateral, autosomal dominant TGFBI-associated anterior corneal dystrophy characterized by:

• Recurrent painful corneal erosions beginning in childhood
• Progressive replacement/disruption of Bowman layer
• Superficial stromal fibrosis and opacification
• Increasing corneal irregularity
• Progressive reduction in visual acuity

It was historically called:

• Corneal dystrophy of Bowman layer type 1 (CDB1)
• Granular corneal dystrophy type III

The modern preferred term is:

Reis-Bücklers corneal dystrophy

Key Clinical Pattern

The classic sequence is:

Childhood recurrent erosions → honeycomb/geographic anterior corneal opacities → progressive superficial scarring and irregular astigmatism

Pain from erosions may become less prominent with age while visual loss from:

• Scar
• Surface irregularity
• Anterior stromal deposits

becomes increasingly important.

Epidemiology

RBCD is:

• Rare
• Usually familial
• Bilateral
• Often symmetric early but potentially asymmetric in severity

Exact prevalence is unknown.

Genetics

RBCD is caused by pathogenic variants in:

TGFBI

located on:

Chromosome 5q31

The older gene name:

BIGH3

has largely been replaced by TGFBI.

Classic Mutation

The mutation most strongly associated with classic RBCD is:

TGFBI p.Arg124Leu (R124L)

Inheritance is:

Autosomal dominant

with variable expressivity.

TGFBI Protein

TGFBI encodes:

Transforming growth factor beta-induced protein (TGFBIp)

also known as:

Keratoepithelin

Mutant TGFBIp accumulates extracellularly in the cornea and produces several distinct corneal dystrophies depending on the specific variant.

Other TGFBI Corneal Dystrophies

TGFBI mutations are also associated with:

• Thiel-Behnke corneal dystrophy
• Granular corneal dystrophy type 1
• Granular corneal dystrophy type 2
• Lattice corneal dystrophy type 1

Phenotype–genotype correlation is therefore clinically useful.

RBCD vs Thiel-Behnke Genetics

A classic exam distinction:

Reis-Bücklers

Usually:

TGFBI p.Arg124Leu

Thiel-Behnke

Usually:

TGFBI p.Arg555Gln

This is more useful today than older classifications based solely on electron microscopy.

Pathophysiology

Mutant TGFBI protein accumulates in the:

• Subepithelial region
• Bowman layer
• Superficial anterior stroma

Bowman layer becomes:

• Fragmented
• Replaced
• Irregular

This disrupts epithelial adhesion and produces:

Recurrent corneal erosions

Repeated erosions and abnormal wound healing cause:

• Subepithelial fibrosis
• Superficial stromal scarring
• Irregular anterior corneal surface

Histopathology

Typical findings include:

• Disruption or absence of Bowman layer
• Fibrocellular tissue replacing Bowman layer
• Anterior stromal deposition
• Irregular epithelium

With light microscopy, deposits may stain:

Red with Masson trichrome

Electron Microscopy

RBCD classically demonstrates:

Rod-shaped or granular electron-dense deposits

within the superficial cornea.

This contrasts with Thiel-Behnke dystrophy, which characteristically demonstrates:

Curly fibers

on electron microscopy.

Electron microscopy is now rarely required because:

• Clinical phenotype
• Genetic testing

can usually establish the diagnosis.

Onset

Symptoms usually begin during:

The first decade of life

often around preschool or early school age.

Children may present with:

• Photophobia
• Tearing
• Eye rubbing
• Recurrent painful red eye
• Blepharospasm

Clinical Presentation

Early symptoms result primarily from:

Recurrent corneal epithelial erosions

Typical episodes include:

• Severe ocular pain
• Foreign-body sensation
• Photophobia
• Tearing
• Conjunctival injection
• Temporary blurred vision

Episodes may last:

• Hours
• Days
• Occasionally longer

Disease Evolution

With increasing age:

• Erosions may become less frequent
• Superficial opacification increases
• Corneal surface becomes more irregular
• Best-corrected vision declines

By adolescence or adulthood, visual symptoms may be dominated by:

• Haze
• Irregular astigmatism
• Scar

rather than recurrent pain.

Slit-Lamp Findings

Early disease shows:

Bilateral central and paracentral subepithelial/anterior stromal opacities

that may become:

• Reticular
• Geographic
• Honeycomb-like

Honeycomb Appearance

A classic finding is:

Irregular gray-white honeycomb or reticular opacification of the anterior central cornea

These lesions primarily involve:

• Bowman layer
• Very anterior stroma

and tend to become more confluent with age.

Advanced Disease

Later findings include:

• Dense gray-white superficial opacity
• Irregular anterior corneal surface
• Loss of normal Bowman layer
• Superficial stromal fibrosis
• Irregular astigmatism

The old description of:

“Curdled milk”

may be encountered in historical literature but is not essential diagnostically.

Corneal Erosions

During an active erosion, examination may show:

• Epithelial defect
• Loose surrounding epithelium
• Fluorescein staining
• Mild stromal edema

The underlying dystrophy remains visible between episodes.

Visual Loss

Vision declines because of:

• Central superficial opacity
• Irregular astigmatism
• Corneal surface distortion
• Progressive fibrosis

Early disease may still have relatively good corrected acuity.

Diagnosis

Diagnosis is usually based on:

• Early age of onset
• Recurrent erosions
• Bilateral honeycomb anterior corneal opacities
• Family history
• Characteristic superficial location

Genetic testing can confirm:

TGFBI-related disease

and distinguish overlapping phenotypes.

Genetic Testing

Testing is particularly useful when:

• Phenotype overlaps with Thiel-Behnke dystrophy
• Family counseling is desired
• Surgical planning is being considered
• Diagnosis is uncertain

Identification of a:

TGFBI p.Arg124Leu variant

strongly supports classic RBCD.

Family Examination

Because inheritance is autosomal dominant:

First-degree relatives should be offered slit-lamp examination

when clinically appropriate.

Genetic counseling may be useful for affected families.

Anterior Segment OCT

AS-OCT may demonstrate:

• Hyperreflective subepithelial deposits
• Bowman layer disruption
• Depth of anterior stromal involvement

This is particularly useful before:

PTK

to estimate treatment depth.

In Vivo Confocal Microscopy

Confocal microscopy may show:

• Highly reflective extracellular material
• Abnormal basal epithelium
• Disturbed Bowman layer
• Superficial stromal deposits

It is usually supportive rather than necessary for diagnosis.

Corneal Topography / Tomography

Useful when evaluating:

• Irregular astigmatism
• Progressive visual decline
• Surgical planning

It may show increasingly irregular corneal optics as fibrosis advances.

Differential Diagnosis

Important differentials include:

• Thiel-Behnke corneal dystrophy
• Epithelial basement membrane dystrophy
• Granular corneal dystrophy
• Lattice corneal dystrophy
• Meesmann corneal dystrophy
• Salzmann nodular degeneration
• Superficial corneal scarring
• Herpes simplex keratitis

Reis-Bücklers vs Thiel-Behnke

These are the most important overlapping conditions.

Reis-Bücklers

• Usually earlier onset
• More severe recurrent erosions
• Honeycomb/geographic anterior opacity
• More rapid progression
• TGFBI p.Arg124Leu
• Rod-like deposits on EM

Thiel-Behnke

• Often somewhat later onset
• Honeycomb superficial opacity can look similar
• Usually slower progression
• TGFBI p.Arg555Gln
• Curly fibers on EM

Genetic testing is the most definitive modern distinction.

Reis-Bücklers vs EBMD

RBCD

• Childhood onset
• Autosomal dominant
• Progressive superficial scarring
• Honeycomb opacities
• Significant visual decline with age

EBMD

• Usually later onset
• Map-dot-fingerprint epithelial findings
• Often much milder
• Does not typically cause the characteristic dense Bowman/anterior stromal honeycomb scar pattern

Reis-Bücklers vs Granular Corneal Dystrophy

Granular dystrophy typically produces:

• Discrete white stromal deposits
• Relatively clear spaces between deposits initially

RBCD is much more:

• Superficial
• Diffuse
• Honeycomb-like

with prominent recurrent erosions early in life.

Reis-Bücklers vs Lattice Dystrophy

Lattice dystrophy typically demonstrates:

• Branching refractile stromal lines
• Amyloid deposition

rather than the superficial honeycomb pattern of RBCD.

Both can produce recurrent erosions.

Treatment Principles

Treatment has two goals:

1. Control recurrent epithelial erosions
2. Restore vision when superficial opacity and irregularity become significant

There is no therapy that corrects the underlying TGFBI mutation.

Treatment of Recurrent Erosions

Initial conservative therapy includes:

• Preservative-free artificial tears
• Lubricating ointment at bedtime
• Hypertonic sodium chloride ointment in selected cases

These reduce friction and epithelial trauma.

Acute Erosion

During a significant epithelial defect, treatment may include:

• Lubrication
• Short-term topical antibiotic prophylaxis
• Oral analgesics
• Cycloplegic when photophobia is significant

Bandage Contact Lens

A bandage contact lens can be used for:

• Large painful erosion
• Persistent epithelial defect
• Recurrent episodes despite lubrication

It provides:

• Mechanical protection
• Pain relief
• Epithelial stabilization

Close follow-up is required because of:

Microbial keratitis risk.

Topical Antibiotic

Antibiotic prophylaxis may be appropriate while:

• A significant epithelial defect is open
• A bandage contact lens is being used

It does not treat the dystrophy itself.

Topical Corticosteroids

Routine topical corticosteroid use solely to:

“Prevent corneal scarring”

during uncomplicated erosions is not standard modern treatment.

Steroids may:

• Delay epithelial healing
• Increase infection risk

They should be reserved for selected inflammatory indications under ophthalmic supervision.

Persistent/Recurrent Surface Disease

For recurrent erosions not controlled conservatively, options include:

• Epithelial debridement
• Superficial keratectomy
• Diamond-burr polishing in selected cases
• Phototherapeutic keratectomy

Because RBCD involves abnormal Bowman layer itself, definitive superficial treatment often needs to address more than loose epithelium alone.

Phototherapeutic Keratectomy

PTK is the preferred surgical treatment for visually significant superficial RBCD when disease depth is suitable.

Excimer laser ablation removes:

• Abnormal superficial tissue
• Fibrotic Bowman-layer material
• Irregular anterior stroma

This can:

• Improve visual acuity
• Regularize the surface
• Reduce recurrent erosions

PTK Indications

Consider PTK for:

• Visually significant superficial opacity
• Irregular astigmatism
• Frequent recurrent erosions
• Superficial scarring

especially when disease remains predominantly anterior.

PTK Advantages

Compared with corneal transplantation, PTK:

• Preserves native cornea
• Avoids intraocular surgery
• Has faster rehabilitation
• Can be repeated in selected cases

PTK Limitations

The main limitation is:

Recurrence

because genetically abnormal keratocytes and TGFBI protein production remain.

Deposits may recur over:

• Years
• Sometimes sooner

Refractive Effect of PTK

Because tissue is removed from the central cornea, PTK may produce:

Hyperopic shift

particularly with deeper ablation.

This should be considered during planning.

Mitomycin C With PTK

Mitomycin C has been used adjunctively in an attempt to reduce:

• Haze
• Recurrence

However:

Evidence that MMC reliably prevents recurrent TGFBI deposition is limited, and it is not a universally required component of PTK.

Use is individualized.

Superficial Keratectomy

When excimer PTK is unavailable, superficial keratectomy may remove:

• Abnormal epithelium
• Fibrotic superficial tissue

It can improve:

• Surface regularity
• Erosion frequency

but recurrence remains possible.

Keratoplasty

Corneal transplantation is reserved for:

• Deep or extensive anterior stromal scarring
• Severe visual loss not amenable to PTK
• Multiple failed superficial procedures

Options include:

• Anterior lamellar keratoplasty
• Deep anterior lamellar keratoplasty in selected cases
• Penetrating keratoplasty

Lamellar vs Penetrating Keratoplasty

Because disease is primarily anterior:

Lamellar approaches are attractive when the deeper stroma and endothelium are healthy.

Advantages include:

• Preservation of endothelium
• Lower rejection risk

PK may be necessary when opacity extends too deeply or lamellar surgery is unsuitable.

Recurrence After Keratoplasty

A major clinical feature of RBCD is:

Recurrence in the graft

because host-derived abnormal TGFBI protein can redeposit in transplanted tissue.

Recurrence may occur after:

• Lamellar keratoplasty
• Penetrating keratoplasty

Therefore transplantation is:

Not curative at the molecular level.

Postoperative Monitoring

After PTK or keratoplasty, monitor for:

• Epithelial healing
• Infection
• Haze
• Refractive change
• Recurrence of deposits
• Recurrent erosions

Pediatric Considerations

Children may have:

• Painful recurrent erosions
• Photophobia
• Eye rubbing
• Reduced visual function

Assess:

• Visual acuity
• Refraction
• Corneal clarity

Significant asymmetric visual loss can theoretically contribute to:

Amblyopia

and should be addressed during visual development.

Prevention

There is:

No known method to prevent development of RBCD

in a genetically affected individual.

General ocular surface protection includes:

• Avoiding unnecessary trauma
• Treating dry eye
• Using lubrication during recurrent erosion-prone periods

Prognosis

RBCD is:

Slowly progressive but recurrent

The natural history commonly includes:

• Painful erosions in childhood
• Increasing superficial opacity during adolescence
• Progressive visual impairment in adulthood

Visual Prognosis

Vision can often be substantially improved with:

• PTK
• Superficial keratectomy
• Keratoplasty in advanced cases

However:

Recurrence remains the central long-term problem.

Complications

Potential complications include:

• Recurrent corneal erosions
• Microbial keratitis
• Progressive superficial scarring
• Irregular astigmatism
• Reduced BCVA
• Recurrence after PTK
• Recurrence after corneal transplantation

Ophthalmology Pearls

• Reis-Bücklers corneal dystrophy is an autosomal dominant TGFBI-associated anterior corneal dystrophy with recurrent childhood erosions and progressive Bowman/anterior stromal scarring.
• The classic mutation is TGFBI p.Arg124Leu (R124L).
• The older gene name BIGH3 has been replaced by TGFBI.
• Symptoms typically begin during the first decade of life with recurrent painful epithelial erosions.
• Slit lamp shows bilateral central honeycomb/geographic gray-white opacities involving Bowman layer and superficial stroma.
• With age, pain from erosions may become less prominent while visual loss from superficial fibrosis and irregular astigmatism increases.
• The most important differential is Thiel-Behnke dystrophy, usually associated with TGFBI p.Arg555Gln.
• RBCD shows rod-like deposits ultrastructurally, whereas Thiel-Behnke shows characteristic curly fibers.
• Modern genetic testing often distinguishes the two more directly than electron microscopy.
• Conservative treatment of erosions includes preservative-free lubrication, nighttime ointment, and bandage contact lens when necessary.
• Routine topical corticosteroids solely to prevent scarring during epithelial erosions are not standard therapy.
• PTK is the principal surgical treatment for visually significant superficial disease, improving both surface regularity and recurrent erosions.
• PTK may produce a hyperopic shift, and recurrence is common because the underlying genetic defect persists.
• MMC has been used with PTK, but evidence that it prevents TGFBI redeposition is limited.
• Lamellar or penetrating keratoplasty is reserved for advanced scarring, but RBCD can recur in the graft.
• There are no known systemic associations; the disorder is primarily confined to the cornea.

Ophthalmology – Refractive Error (Myopia, Hyperopia, Astigmatism)

Basics

Description

A refractive error exists when light entering the unaccommodated eye does not focus precisely on the retina.

The refractive state depends mainly on the relationship between:

• Corneal power
• Crystalline lens power
• Anterior chamber depth
• Axial length

The three major refractive errors are:

• Myopia
• Hyperopia
• Astigmatism

Emmetropia

In an emmetropic eye, parallel rays from a distant object focus:

On the retina without accommodation.

Emmetropization during childhood coordinates:

• Axial growth
• Corneal curvature
• Lens power

so that refractive error tends toward a relatively narrow range.

Myopia

Myopia occurs when parallel rays focus:

In front of the retina

with accommodation relaxed.

It is corrected with:

Minus lenses

which diverge incoming light.

Hyperopia

Hyperopia occurs when parallel rays would focus:

Behind the retina

with accommodation relaxed.

It is corrected with:

Plus lenses

which converge incoming light.

Astigmatism

In astigmatism, optical power differs between meridians, so light does not converge to a single point focus.

Instead, two principal focal lines are formed.

Astigmatism may be:

• Regular
• Irregular

Regular Astigmatism

In regular astigmatism:

• The two principal meridians are approximately perpendicular

Common forms include:

• With-the-rule
• Against-the-rule
• Oblique astigmatism

With-the-Rule Astigmatism

The vertical meridian is relatively steeper.

In minus-cylinder notation, the cylinder axis is typically near:

180°

Against-the-Rule Astigmatism

The horizontal meridian is relatively steeper.

In minus-cylinder notation, the cylinder axis is typically near:

90°

Oblique Astigmatism

Principal meridians lie away from the usual vertical/horizontal axes, often around:

• 45°
• 135°

Oblique astigmatism may be especially noticeable symptomatically because adaptation can be more difficult.

Irregular Astigmatism

In irregular astigmatism, the optical surface cannot be described adequately by two perpendicular principal meridians.

Causes include:

• Keratoconus
• Corneal scar
• Corneal ectasia
• Pterygium
• Post-surgical irregularity
• Corneal degeneration

Irregular astigmatism often cannot be fully corrected with spectacles.

Epidemiology

Refractive error is one of the most common causes of reduced vision worldwide.

Its prevalence varies by:

• Age
• Ethnicity
• Geography
• Education
• Environmental exposure

Myopia is particularly common in:

• East and Southeast Asia
• Urbanized populations
• Highly educated populations

and its prevalence has risen substantially over recent decades.

Genetics

Refractive error has a strong heritable component.

Myopia, hyperopia, and astigmatism are influenced by:

• Multiple genes
• Ocular biometric traits
• Environmental exposures

Most common refractive error is:

Polygenic and multifactorial

rather than caused by a single gene.

Myopia – Pathophysiology

Most clinically important myopia is:

Axial myopia

in which the eye is too long for its optical power.

A relatively small increase in axial length can produce substantial refractive change.

Axial Length

A rough clinical principle:

~1 mm of axial elongation produces approximately 2.5–3 D of myopia

although the exact relationship varies.

High myopia usually reflects:

• Excessive axial elongation

rather than simply excessive corneal curvature.

Refractive Myopia

Less commonly, myopia results from excessive optical power rather than axial elongation.

Examples include:

• Increased corneal curvature
• Lenticular myopia
• Nuclear sclerosis
• Lens swelling

Myopic Shift in Cataract

Nuclear sclerosis may increase the refractive index of the lens and produce:

A myopic shift

sometimes called:

Second sight

because an older hyperopic or presbyopic patient may temporarily read without glasses again.

Myopia Risk Factors

Important risk factors include:

• Family history
• Limited outdoor time
• Greater near-work/educational exposure
• Urban environment
• East Asian ancestry
• Earlier age of onset

Outdoor Time

One of the best-supported environmental protective factors against childhood myopia onset is:

More time spent outdoors

Outdoor exposure appears to reduce the risk of developing myopia, although it is less certain how strongly it slows progression once myopia is established.

Near Work

Near work is associated with myopia development, particularly:

• Prolonged uninterrupted near tasks
• Very short working distance

The relationship is weaker than the protective effect of outdoor time.

Hyperopia – Pathophysiology

Hyperopia is commonly caused by:

Axial length that is too short for the optical power of the eye

Other contributors include:

• Flat cornea
• Reduced lens power
• Aphakia

Accommodation and Hyperopia

Young hyperopes may compensate using:

Accommodation

Therefore they may have:

• Clear distance vision
• Clear near vision
• No symptoms

despite measurable hyperopia.

Manifest Hyperopia

The portion of hyperopia detected without cycloplegia is:

Manifest hyperopia

Latent Hyperopia

Additional hyperopia uncovered after cycloplegia is:

Latent hyperopia

It is particularly important in:

• Children
• Young adults
• Accommodative esotropia

Total Hyperopia

Total hyperopia is approximately:

Manifest + latent hyperopia

and is best estimated with adequate cycloplegia.

Hyperopia and Age

Hyperopia itself does not necessarily increase dramatically with age, but symptoms often worsen because:

Accommodation progressively decreases

As presbyopia develops, previously compensated hyperopia becomes clinically apparent.

Hyperopia and Angle Closure

Hyperopic eyes often have:

• Shorter axial length
• Shallower anterior chamber
• Narrower angles

and therefore have increased risk for:

Primary angle-closure disease

especially with aging.

Astigmatism – Optical Basis

Astigmatism may arise from:

• Cornea
• Crystalline lens
• Posterior corneal surface

The anterior cornea contributes most of the clinically measured astigmatism.

Corneal vs Refractive Astigmatism

Keratometry measures primarily:

Anterior corneal curvature

whereas manifest refraction measures:

Total refractive astigmatism

which includes:

• Anterior cornea
• Posterior cornea
• Lens

This difference is important in:

• Toric IOL planning
• Refractive surgery
• Contact lens fitting

Symptoms

Symptoms depend on:

• Magnitude
• Type of refractive error
• Age
• Accommodation
• Visual demand

Myopia Symptoms

Typical complaints include:

• Blurred distance vision
• Squinting
• Sitting close to television or screen
• Difficulty seeing classroom board or road signs

Near vision may remain clear without correction.

Hyperopia Symptoms

Possible symptoms include:

• Near blur
• Eyestrain
• Frontal headache
• Fatigue with reading
• Intermittent blur
• Difficulty sustaining near work

Young patients may remain asymptomatic because of accommodation.

Astigmatism Symptoms

Symptoms may include:

• Blur at distance and near
• Ghosting
• Distortion
• Headache
• Eyestrain
• Difficulty with fine detail
• Night-driving glare

Asthenopia

Refractive error may contribute to:

Asthenopia

including:

• Frontal headache
• Eye fatigue
• Brow ache
• Difficulty sustaining near work

However, headache should not automatically be attributed to refractive error without appropriate clinical evaluation.

Pediatric Importance

Uncorrected significant refractive error can cause:

Amblyopia

particularly:

• High bilateral ametropia
• Anisometropia
• High astigmatism
• Hyperopia associated with esotropia

Anisometropia

Anisometropia is unequal refractive error between the two eyes.

It may cause:

• Unequal retinal image quality
• Suppression
• Amblyopia
• Reduced stereopsis

in children.

Aniseikonia

Spectacle correction of large anisometropia can produce different retinal image sizes:

Aniseikonia

This may cause:

• Eyestrain
• Diplopia
• Reduced stereopsis
• Poor spectacle tolerance

Contact lenses often reduce this problem.

Accommodative Esotropia

Significant hyperopia may cause excessive accommodative effort.

Because accommodation is linked to convergence:

Accommodation → convergence

some children develop:

Accommodative esotropia

Hyperopic Correction in Accommodative Esotropia

Children with accommodative esotropia generally receive:

Full cycloplegic hyperopic correction initially

to reduce accommodative convergence.

Diagnosis

Diagnosis requires measurement of refractive state and assessment of ocular health.

Core components include:

• Distance visual acuity
• Near visual acuity
• Pinhole acuity
• Objective refraction
• Subjective refraction
• Cycloplegic refraction when indicated

Pinhole Test

Improvement in visual acuity through a pinhole suggests that decreased vision is at least partly:

Optical/refractive

because the pinhole reduces the blur circle.

However, lack of pinhole improvement does not completely exclude refractive error.

Objective Refraction

Objective techniques include:

• Retinoscopy
• Autorefraction

These provide a starting estimate without requiring subjective responses.

Retinoscopy

Retinoscopy is especially valuable in:

• Children
• Nonverbal patients
• Developmental delay
• Poor subjective responders
• Irregular reflexes

It remains a fundamental method for objective refraction.

Autorefraction

Autorefraction is useful for:

• Rapid screening
• Starting subjective refraction

but should generally not replace:

Clinical refinement

especially in:

• Young patients
• High accommodation
• Irregular corneas

Manifest Refraction

Manifest refraction is performed without cycloplegia.

It reflects the patient’s functional refractive state but can be influenced by:

Accommodation

Young patients may be:

• Over-minused
• Under-plussed

if accommodation is not controlled.

Cycloplegic Refraction

Cycloplegic refraction temporarily eliminates accommodation.

It is particularly important in:

• Children
• Suspected hyperopia
• Accommodative esotropia
• Unexplained reduced vision
• Suspected accommodative spasm
• Large discrepancy between objective and subjective refraction

Cycloplegic Agents

Common agents include:

• Cyclopentolate
• Tropicamide in selected situations
• Atropine for stronger/prolonged cycloplegia when clinically required

Cyclopentolate is commonly used for routine pediatric cycloplegic refraction.

Important Modern Correction

There is no universal rule that a fixed amount such as:

−0.25 D

must automatically be added after every cycloplegic refraction.

Final prescribing should be based on:

• Age
• Symptoms
• Alignment
• Accommodation
• Visual acuity
• Refractive findings

Keratometry

Keratometry measures:

• Central corneal curvature

and estimates:

• Corneal astigmatism

It is useful for:

• Contact lenses
• Cataract surgery
• Toric IOL planning
• Corneal disease screening

Corneal Topography and Tomography

These are important when astigmatism is:

• High
• Irregular
• Progressive
• Asymmetric

They help diagnose:

• Keratoconus
• Corneal ectasia
• Pellucid marginal degeneration
• Post-surgical ectasia

Jackson Cross Cylinder

The JCC is used during subjective refraction to refine:

• Cylinder axis
• Cylinder power

It is particularly useful in regular astigmatism.

Spherical Equivalent

The spherical equivalent is:

Sphere + ½ cylinder

It is useful for:

• Comparing prescriptions
• Research
• Some prescribing adjustments

but does not fully describe the optical effect of astigmatism.

Treatment Principles

Refractive error can be corrected with:

• Spectacles
• Contact lenses
• Refractive surgery
• Intraocular lens-based procedures

Choice depends on:

• Age
• Refractive magnitude
• Corneal anatomy
• Ocular health
• Lifestyle
• Patient preference

Spectacles

Spectacles are:

The simplest and safest form of optical correction

and can correct:

• Myopia
• Hyperopia
• Regular astigmatism
• Presbyopia

Correcting Myopia

A practical goal is:

Full or appropriate distance correction without unnecessary over-minus

Over-minus can:

• Stimulate accommodation
• Cause eyestrain
• Distort binocular balance

especially in young patients.

Myopic Undercorrection

An important modern correction:

Deliberately undercorrecting childhood myopia does not prevent progression and may worsen progression in some patients.

Children should generally receive:

Appropriate full distance correction

unless there is a specific clinical reason not to.

Correcting Hyperopia

Correction depends on:

• Age
• Symptoms
• Magnitude
• Accommodation
• Binocular alignment
• Presence of amblyopia

Asymptomatic low hyperopia in a young patient may not require full correction.

Hyperopia in Children

Full or near-full correction is especially important when there is:

• Accommodative esotropia
• Amblyopia
• Significant high hyperopia
• Reduced visual function

Correcting Astigmatism

Significant astigmatism should be corrected in children to prevent:

Meridional amblyopia

Children generally adapt better than adults to:

• Large cylinder corrections
• Changes in axis

Adult Astigmatic Adaptation

Adults receiving a new large cylinder or major axis change may experience:

• Floor tilt
• Spatial distortion
• Dizziness
• Headache

Gradual adaptation often occurs over:

• Days to weeks

Large unnecessary reductions in accurate cylinder should not be routine, but modification may occasionally improve tolerance.

Contact Lenses

Contact lenses can correct:

• Myopia
• Hyperopia
• Astigmatism
• Anisometropia

Advantages include:

• Wider visual field
• Less spectacle magnification/minification
• Better optical quality in high refractive error

Contact Lenses in High Myopia

Compared with spectacles, contact lenses reduce:

• Minification
• Peripheral distortion
• Prism effects

and may provide better visual quality.

Contact Lenses in High Hyperopia

Contact lenses reduce:

• Spectacle magnification
• Ring scotoma
• Peripheral distortion

and may be especially beneficial in:

• Aphakia
• High anisometropia

Toric Contact Lenses

Regular astigmatism may be corrected with:

• Soft toric lenses
• Rigid gas-permeable lenses

Rigid Lenses for Irregular Astigmatism

Rigid gas-permeable or scleral lenses may provide major improvement in:

• Keratoconus
• Corneal scars
• Irregular astigmatism

by creating a more regular anterior refractive surface.

Myopia Control in Children

A major modern development is active treatment to slow:

Childhood myopia progression and axial elongation.

This is particularly important because higher lifetime myopia increases risk of:

• Retinal detachment
• Myopic maculopathy
• Glaucoma
• Cataract

Myopia-Control Options

Evidence-based options include:

• Low-dose atropine
• Orthokeratology
• Dual-focus/multifocal soft contact lenses
• Specialized myopia-control spectacle lenses
• Increased outdoor time

The most appropriate strategy depends on:

• Age
• Rate of progression
• Axial length
• Refractive error
• Patient preference
• Local availability

Low-Dose Atropine

Low-concentration atropine may slow myopia progression.

Commonly studied concentrations include:

• 0.01%
• 0.025%
• 0.05%

Higher low-dose concentrations tend to have:

• Greater efficacy
• More photophobia
• More near blur

Exact concentration should be individualized.

Orthokeratology

Orthokeratology uses overnight rigid lenses to temporarily flatten central cornea.

It can:

• Correct daytime myopia
• Slow axial elongation in many children

Risks include:

• Microbial keratitis
• Corneal staining
• Lens-related complications

Strict hygiene is essential.

Multifocal / Dual-Focus Contact Lenses

Specialized soft contact lenses can create:

• Central distance correction
• Peripheral or simultaneous myopic defocus

and can reduce myopia progression in selected children.

Myopia-Control Spectacle Lenses

Newer designs use peripheral optical strategies to create myopic defocus while maintaining central clarity.

These can slow:

• Refractive progression
• Axial elongation

without contact lens risks.

Outdoor Time Recommendation

For children, encouraging approximately:

2 hours or more outdoors daily when practical

is commonly recommended as part of myopia prevention strategies.

This should complement—not replace—optical or pharmacologic treatment in progressing myopia.

High Myopia

Definitions vary, but high myopia is commonly considered approximately:

≤ −6.00 D

and/or excessive axial elongation.

The important distinction is whether there is associated structural damage.

Pathologic Myopia

Pathologic myopia refers to myopia associated with degenerative structural changes such as:

• Posterior staphyloma
• Myopic maculopathy
• Lacquer cracks
• Patchy/chorioretinal atrophy
• Myopic CNV

High refractive error alone does not automatically equal pathologic myopia.

Complications of High Myopia

High axial myopia increases risk of:

• Retinal tear/detachment
• Posterior vitreous detachment
• Lattice degeneration
• Myopic macular degeneration
• Myopic CNV
• Foveoschisis
• Macular hole
• Open-angle glaucoma
• Earlier cataract

Hyperopia Complications

Significant hyperopia is associated with:

• Accommodative esotropia
• Amblyopia
• Anisometropia
• Narrow angles
• Angle-closure disease

Astigmatism Complications

Astigmatism itself does not cause keratoconus.

Instead:

Increasing or irregular astigmatism may be a sign of keratoconus.

This distinction is important.

Keratoconus Red Flags

Consider corneal tomography when there is:

• Increasing cylinder
• New oblique astigmatism
• Reduced BCVA despite refraction
• Scissoring retinoscopic reflex
• Progressive asymmetry
• Family history of keratoconus
• Frequent eye rubbing

Refractive Surgery

Corneal refractive surgery can correct selected cases of:

• Myopia
• Hyperopia
• Astigmatism

Options include:

• LASIK
• PRK
• SMILE for selected refractive ranges
• Other laser platforms depending on region

LASIK

LASIK reshapes the corneal stroma using an excimer laser beneath a flap.

Advantages:

• Rapid visual recovery
• Minimal discomfort

Potential complications include:

• Dry eye
• Flap complications
• Ectasia
• Night-vision symptoms
• Residual refractive error

PRK

PRK removes corneal epithelium before stromal ablation.

Advantages:

• No flap
• May be preferred with thinner corneas or certain occupational considerations

Disadvantages:

• More postoperative discomfort
• Slower recovery
• Haze risk

SMILE

Small-incision lenticule extraction is primarily used for:

• Myopia
• Myopic astigmatism

depending on regulatory approval and platform.

Potential advantages include:

• No large corneal flap
• Less early corneal nerve disruption than LASIK in some cases

Refractive Surgery Limits

Older fixed rules such as:

• “LASIK corrects up to 10 D myopia”
• “6 D hyperopia”
• “4 D astigmatism”

are oversimplified.

Eligibility depends on:

• Corneal thickness
• Tomography
• Optical zone
• Residual stromal bed
• Age
• Stability
• Dry eye
• Pupil size
• Device approval

Phakic Intraocular Lens

Phakic IOLs are useful for selected patients with:

• High myopia
• Thin corneas
• Refractive errors outside comfortable laser ranges

Advantages include:

• Excellent optical quality
• Preservation of accommodation

Potential risks include:

• Cataract
• Endothelial cell loss
• IOP elevation
• Intraocular inflammation
• Infection

Clear Lens Extraction

Refractive lens exchange may be considered in selected adults with:

• Very high hyperopia
• Presbyopia
• Lens-related anatomy unsuitable for corneal surgery

However, it sacrifices:

Natural accommodation

and carries intraocular surgical risks.

High Myopia and Lens Extraction

In younger highly myopic patients, refractive lens exchange deserves caution because of:

Retinal detachment risk

and loss of accommodation.

Phakic IOLs are often preferable when anatomy permits.

Intrastromal Corneal Ring Segments

Corneal ring segments are not routinely used simply to correct ordinary low myopia anymore.

Their modern role is primarily in selected cases of:

• Keratoconus
• Corneal ectasia

to regularize corneal shape.

Follow-Up in Children

Children with significant refractive error should be monitored for:

• Visual acuity
• Amblyopia
• Strabismus
• Refractive progression

Children with progressing myopia may also benefit from:

Serial axial length measurement

when available.

Follow-Up in High Myopia

Patients with high myopia require attention to:

• Peripheral retina
• Macula
• Optic nerve
• IOP

New:

• Flashes
• Floaters
• Curtain/shadow
• Sudden visual decline

require urgent retinal evaluation.

Age-Related Changes

Myopia

Childhood myopia often progresses through:

• School years
• Adolescence

and may continue into early adulthood.

Progression is not guaranteed to stop at age 18.

Hyperopia

Children often undergo:

Partial emmetropization

with decreasing hyperopia during early development.

Later symptoms may increase as accommodation declines.

Astigmatism With Aging

An important correction:

The typical age-related trend is often a shift from:

With-the-rule astigmatism in younger adults → against-the-rule astigmatism in older adults

rather than increasing with-the-rule astigmatism with age.

Spectacle Intolerance

If new spectacles are not tolerated, check:

• Prescription accuracy
• Pupillary distance
• Optical centers
• Cylinder axis
• Lens fabrication
• Frame fit
• Vertex distance
• Pantoscopic tilt
• Face-form wrap

Also compare with the patient’s:

• Habitual prescription

Large Prescription Changes

Rapid large changes in:

• Sphere
• Cylinder
• Axis

may be difficult to adapt to.

Before arbitrarily reducing the prescription, confirm:

• Refraction accuracy
• Ocular pathology
• Corneal shape

Anisometropia and Spectacle Tolerance

There is no absolute rule that adults cannot tolerate more than:

2 D of anisometropia

Some patients tolerate more, while others tolerate less.

Tolerance depends on:

• Optical magnification differences
• Age
• Duration
• Binocular function
• Lens type

Contact lenses substantially reduce spectacle-induced aniseikonia.

Prognosis

Most refractive errors can be corrected to:

Normal or near-normal visual acuity

provided there is no:

• Amblyopia
• Corneal disease
• Retinal disease
• Optic nerve disease

The major long-term concern is not refractive blur itself but associated structural disease, especially in:

High axial myopia.

Ophthalmology Pearls

• Myopia focuses distant light in front of the retina, hyperopia behind the retina, and astigmatism produces different focal powers in different meridians.
• Most clinically important high myopia is caused by excessive axial elongation.
• Young hyperopes may hide substantial refractive error through accommodation, making cycloplegic refraction especially important.
• Cycloplegic refraction is essential in children with significant hyperopia, accommodative esotropia, unexplained reduced vision, or suspected accommodative spasm.
• Children with accommodative esotropia generally require full cycloplegic hyperopic correction initially.
• Significant anisometropia and astigmatism in children can cause amblyopia even when neither eye has obvious structural disease.
• Deliberately undercorrecting childhood myopia is not an evidence-based myopia-control strategy and may worsen progression.
• Modern childhood myopia control includes low-dose atropine, orthokeratology, dual-focus/multifocal contact lenses, specialized spectacle lenses, and increased outdoor time.
• Increasing outdoor exposure is one of the best-supported strategies for reducing the risk of myopia onset.
• High myopia increases risk of retinal detachment, myopic maculopathy, CNV, glaucoma, cataract, and tractional macular disease.
• High myopia and pathologic myopia are not synonymous; pathologic myopia implies structural degenerative change.
• Hyperopia is associated with accommodative esotropia, amblyopia, and increased angle-closure risk.
• Irregular or progressively increasing astigmatism should raise suspicion for keratoconus or corneal ectasia.
• Astigmatism generally shifts with age from with-the-rule toward against-the-rule.
• Rigid or scleral contact lenses are particularly useful for irregular astigmatism, because they create a regular refractive surface.
• Modern refractive surgery candidacy cannot be defined by simple fixed diopter limits; it depends on corneal tomography, thickness, ocular surface, refractive stability, and platform-specific parameters.
• Phakic IOLs are an important option for high refractive errors with otherwise healthy phakic eyes, particularly when corneal laser surgery is unsuitable.
• Large anisometropia is often better tolerated with contact lenses than spectacles because contact lenses reduce magnification/minification differences.

Emmetropia In an emmetropic eye, parallel rays from a distant object focus: On the retina without accommodation. Emmetropization during childhood coordinates:  Axial growth Corneal curvature Lens power  so that refractive error tends toward a relatively narrow range.

Myopia Myopia occurs when parallel rays focus: In front of the retina with accommodation relaxed. It is corrected with: Minus lenses which diverge incoming light.

Hyperopia Hyperopia occurs when parallel rays would focus: Behind the retina with accommodation relaxed. It is corrected with: Plus lenses which converge incoming light.

Astigmatism In astigmatism, optical power differs between meridians, so light does not converge to a single point focus. Instead, two principal focal lines are formed. Astigmatism may be:  Regular Irregular

Regular Astigmatism In regular astigmatism:  The two principal meridians are approximately perpendicular  Common forms include:  With-the-rule Against-the-rule Oblique astigmatism

With-the-Rule Astigmatism The vertical meridian is relatively steeper. In minus-cylinder notation, the cylinder axis is typically near: 180°

Against-the-Rule Astigmatism The horizontal meridian is relatively steeper. In minus-cylinder notation, the cylinder axis is typically near: 90°

Oblique Astigmatism Principal meridians lie away from the usual vertical/horizontal axes, often around:  45° 135°  Oblique astigmatism may be especially noticeable symptomatically because adaptation can be more difficult.

Irregular Astigmatism In irregular astigmatism, the optical surface cannot be described adequately by two perpendicular principal meridians. Causes include:  Keratoconus Corneal scar Corneal ectasia Pterygium Post-surgical irregularity Corneal degeneration  Irregular astigmatism often cannot be fully corrected with spectacles.

Epidemiology Refractive error is one of the most common causes of reduced vision worldwide. Its prevalence varies by:  Age Ethnicity Geography Education Environmental exposure  Myopia is particularly common in:  East and Southeast Asia Urbanized populations Highly educated populations  and its prevalence has risen substantially over recent decades.

Genetics Refractive error has a strong heritable component. Myopia, hyperopia, and astigmatism are influenced by:  Multiple genes Ocular biometric traits Environmental exposures  Most common refractive error is: Polygenic and multifactorial rather than caused by a single gene.

Myopia – Pathophysiology Most clinically important myopia is: Axial myopia in which the eye is too long for its optical power. A relatively small increase in axial length can produce substantial refractive change.

Axial Length A rough clinical principle: ~1 mm of axial elongation produces approximately 2.5–3 D of myopia although the exact relationship varies. High myopia usually reflects:  Excessive axial elongation  rather than simply excessive corneal curvature.

Refractive Myopia Less commonly, myopia results from excessive optical power rather than axial elongation. Examples include:  Increased corneal curvature Lenticular myopia Nuclear sclerosis Lens swelling

Myopic Shift in Cataract Nuclear sclerosis may increase the refractive index of the lens and produce: A myopic shift sometimes called: Second sight because an older hyperopic or presbyopic patient may temporarily read without glasses again.

Myopia Risk Factors Important risk factors include:  Family history Limited outdoor time Greater near-work/educational exposure Urban environment East Asian ancestry Earlier age of onset

Outdoor Time One of the best-supported environmental protective factors against childhood myopia onset is: More time spent outdoors Outdoor exposure appears to reduce the risk of developing myopia, although it is less certain how strongly it slows progression once myopia is established.

Near Work Near work is associated with myopia development, particularly:  Prolonged uninterrupted near tasks Very short working distance  The relationship is weaker than the protective effect of outdoor time.

Hyperopia – Pathophysiology Hyperopia is commonly caused by: Axial length that is too short for the optical power of the eye Other contributors include:  Flat cornea Reduced lens power Aphakia

Accommodation and Hyperopia Young hyperopes may compensate using: Accommodation Therefore they may have:  Clear distance vision Clear near vision No symptoms  despite measurable hyperopia.

Manifest Hyperopia The portion of hyperopia detected without cycloplegia is: Manifest hyperopia

Latent Hyperopia Additional hyperopia uncovered after cycloplegia is: Latent hyperopia It is particularly important in:  Children Young adults Accommodative esotropia

Total Hyperopia Total hyperopia is approximately: Manifest + latent hyperopia and is best estimated with adequate cycloplegia.

Hyperopia and Age Hyperopia itself does not necessarily increase dramatically with age, but symptoms often worsen because: Accommodation progressively decreases As presbyopia develops, previously compensated hyperopia becomes clinically apparent.

Hyperopia and Angle Closure Hyperopic eyes often have:  Shorter axial length Shallower anterior chamber Narrower angles  and therefore have increased risk for: Primary angle-closure disease especially with aging.

Astigmatism – Optical Basis Astigmatism may arise from:  Cornea Crystalline lens Posterior corneal surface  The anterior cornea contributes most of the clinically measured astigmatism.

Corneal vs Refractive Astigmatism Keratometry measures primarily: Anterior corneal curvature whereas manifest refraction measures: Total refractive astigmatism which includes:  Anterior cornea Posterior cornea Lens  This difference is important in:  Toric IOL planning Refractive surgery Contact lens fitting

Symptoms Symptoms depend on:  Magnitude Type of refractive error Age Accommodation Visual demand

Myopia Symptoms Typical complaints include:  Blurred distance vision Squinting Sitting close to television or screen Difficulty seeing classroom board or road signs  Near vision may remain clear without correction.

Hyperopia Symptoms Possible symptoms include:  Near blur Eyestrain Frontal headache Fatigue with reading Intermittent blur Difficulty sustaining near work  Young patients may remain asymptomatic because of accommodation.

Astigmatism Symptoms Symptoms may include:  Blur at distance and near Ghosting Distortion Headache Eyestrain Difficulty with fine detail Night-driving glare

Asthenopia Refractive error may contribute to: Asthenopia including:  Frontal headache Eye fatigue Brow ache Difficulty sustaining near work  However, headache should not automatically be attributed to refractive error without appropriate clinical evaluation.

Pediatric Importance Uncorrected significant refractive error can cause: Amblyopia particularly:  High bilateral ametropia Anisometropia High astigmatism Hyperopia associated with esotropia

Anisometropia Anisometropia is unequal refractive error between the two eyes. It may cause:  Unequal retinal image quality Suppression Amblyopia Reduced stereopsis  in children.

Aniseikonia Spectacle correction of large anisometropia can produce different retinal image sizes: Aniseikonia This may cause:  Eyestrain Diplopia Reduced stereopsis Poor spectacle tolerance  Contact lenses often reduce this problem.

Accommodative Esotropia Significant hyperopia may cause excessive accommodative effort. Because accommodation is linked to convergence: Accommodation → convergence some children develop: Accommodative esotropia

Hyperopic Correction in Accommodative Esotropia Children with accommodative esotropia generally receive: Full cycloplegic hyperopic correction initially to reduce accommodative convergence.

Diagnosis Diagnosis requires measurement of refractive state and assessment of ocular health. Core components include:  Distance visual acuity Near visual acuity Pinhole acuity Objective refraction Subjective refraction Cycloplegic refraction when indicated

Pinhole Test Improvement in visual acuity through a pinhole suggests that decreased vision is at least partly: Optical/refractive because the pinhole reduces the blur circle. However, lack of pinhole improvement does not completely exclude refractive error.

Objective Refraction Objective techniques include:  Retinoscopy Autorefraction  These provide a starting estimate without requiring subjective responses.

Retinoscopy Retinoscopy is especially valuable in:  Children Nonverbal patients Developmental delay Poor subjective responders Irregular reflexes  It remains a fundamental method for objective refraction.

Autorefraction Autorefraction is useful for:  Rapid screening Starting subjective refraction  but should generally not replace: Clinical refinement especially in:  Young patients High accommodation Irregular corneas

Manifest Refraction Manifest refraction is performed without cycloplegia. It reflects the patient’s functional refractive state but can be influenced by: Accommodation Young patients may be:  Over-minused Under-plussed  if accommodation is not controlled.

Cycloplegic Refraction Cycloplegic refraction temporarily eliminates accommodation. It is particularly important in:  Children Suspected hyperopia Accommodative esotropia Unexplained reduced vision Suspected accommodative spasm Large discrepancy between objective and subjective refraction

Cycloplegic Agents Common agents include:  Cyclopentolate Tropicamide in selected situations Atropine for stronger/prolonged cycloplegia when clinically required  Cyclopentolate is commonly used for routine pediatric cycloplegic refraction.

Important Modern Correction There is no universal rule that a fixed amount such as: −0.25 D must automatically be added after every cycloplegic refraction. Final prescribing should be based on:  Age Symptoms Alignment Accommodation Visual acuity Refractive findings

Keratometry Keratometry measures:  Central corneal curvature  and estimates:  Corneal astigmatism  It is useful for:  Contact lenses Cataract surgery Toric IOL planning Corneal disease screening

Corneal Topography and Tomography These are important when astigmatism is:  High Irregular Progressive Asymmetric  They help diagnose:  Keratoconus Corneal ectasia Pellucid marginal degeneration Post-surgical ectasia

Jackson Cross Cylinder The JCC is used during subjective refraction to refine:  Cylinder axis Cylinder power  It is particularly useful in regular astigmatism.

Spherical Equivalent The spherical equivalent is: Sphere + ½ cylinder It is useful for:  Comparing prescriptions Research Some prescribing adjustments  but does not fully describe the optical effect of astigmatism.

Treatment Principles Refractive error can be corrected with:  Spectacles Contact lenses Refractive surgery Intraocular lens-based procedures  Choice depends on:  Age Refractive magnitude Corneal anatomy Ocular health Lifestyle Patient preference

Spectacles Spectacles are: The simplest and safest form of optical correction and can correct:  Myopia Hyperopia Regular astigmatism Presbyopia

Correcting Myopia A practical goal is: Full or appropriate distance correction without unnecessary over-minus Over-minus can:  Stimulate accommodation Cause eyestrain Distort binocular balance  especially in young patients.

Myopic Undercorrection An important modern correction: Deliberately undercorrecting childhood myopia does not prevent progression and may worsen progression in some patients. Children should generally receive: Appropriate full distance correction unless there is a specific clinical reason not to.

Correcting Hyperopia Correction depends on:  Age Symptoms Magnitude Accommodation Binocular alignment Presence of amblyopia  Asymptomatic low hyperopia in a young patient may not require full correction.

Hyperopia in Children Full or near-full correction is especially important when there is:  Accommodative esotropia Amblyopia Significant high hyperopia Reduced visual function

Correcting Astigmatism Significant astigmatism should be corrected in children to prevent: Meridional amblyopia Children generally adapt better than adults to:  Large cylinder corrections Changes in axis

Adult Astigmatic Adaptation Adults receiving a new large cylinder or major axis change may experience:  Floor tilt Spatial distortion Dizziness Headache  Gradual adaptation often occurs over:  Days to weeks  Large unnecessary reductions in accurate cylinder should not be routine, but modification may occasionally improve tolerance.

Contact Lenses Contact lenses can correct:  Myopia Hyperopia Astigmatism Anisometropia  Advantages include:  Wider visual field Less spectacle magnification/minification Better optical quality in high refractive error

Contact Lenses in High Myopia Compared with spectacles, contact lenses reduce:  Minification Peripheral distortion Prism effects  and may provide better visual quality.

Contact Lenses in High Hyperopia Contact lenses reduce:  Spectacle magnification Ring scotoma Peripheral distortion  and may be especially beneficial in:  Aphakia High anisometropia

Toric Contact Lenses Regular astigmatism may be corrected with:  Soft toric lenses Rigid gas-permeable lenses

Rigid Lenses for Irregular Astigmatism Rigid gas-permeable or scleral lenses may provide major improvement in:  Keratoconus Corneal scars Irregular astigmatism  by creating a more regular anterior refractive surface.

Myopia Control in Children A major modern development is active treatment to slow: Childhood myopia progression and axial elongation. This is particularly important because higher lifetime myopia increases risk of:  Retinal detachment Myopic maculopathy Glaucoma Cataract

Myopia-Control Options Evidence-based options include:  Low-dose atropine Orthokeratology Dual-focus/multifocal soft contact lenses Specialized myopia-control spectacle lenses Increased outdoor time  The most appropriate strategy depends on:  Age Rate of progression Axial length Refractive error Patient preference Local availability

Low-Dose Atropine Low-concentration atropine may slow myopia progression. Commonly studied concentrations include:  0.01% 0.025% 0.05%  Higher low-dose concentrations tend to have:  Greater efficacy More photophobia More near blur  Exact concentration should be individualized.

Orthokeratology Orthokeratology uses overnight rigid lenses to temporarily flatten central cornea. It can:  Correct daytime myopia Slow axial elongation in many children  Risks include:  Microbial keratitis Corneal staining Lens-related complications  Strict hygiene is essential.

Multifocal / Dual-Focus Contact Lenses Specialized soft contact lenses can create:  Central distance correction Peripheral or simultaneous myopic defocus  and can reduce myopia progression in selected children.

Myopia-Control Spectacle Lenses Newer designs use peripheral optical strategies to create myopic defocus while maintaining central clarity. These can slow:  Refractive progression Axial elongation  without contact lens risks.

Outdoor Time Recommendation For children, encouraging approximately: 2 hours or more outdoors daily when practical is commonly recommended as part of myopia prevention strategies. This should complement—not replace—optical or pharmacologic treatment in progressing myopia.

High Myopia Definitions vary, but high myopia is commonly considered approximately: ≤ −6.00 D and/or excessive axial elongation. The important distinction is whether there is associated structural damage.

Pathologic Myopia Pathologic myopia refers to myopia associated with degenerative structural changes such as:  Posterior staphyloma Myopic maculopathy Lacquer cracks Patchy/chorioretinal atrophy Myopic CNV  High refractive error alone does not automatically equal pathologic myopia.

Complications of High Myopia High axial myopia increases risk of:  Retinal tear/detachment Posterior vitreous detachment Lattice degeneration Myopic macular degeneration Myopic CNV Foveoschisis Macular hole Open-angle glaucoma Earlier cataract

Hyperopia Complications Significant hyperopia is associated with:  Accommodative esotropia Amblyopia Anisometropia Narrow angles Angle-closure disease

Astigmatism Complications Astigmatism itself does not cause keratoconus. Instead: Increasing or irregular astigmatism may be a sign of keratoconus. This distinction is important.

Keratoconus Red Flags Consider corneal tomography when there is:  Increasing cylinder New oblique astigmatism Reduced BCVA despite refraction Scissoring retinoscopic reflex Progressive asymmetry Family history of keratoconus Frequent eye rubbing

Refractive Surgery Corneal refractive surgery can correct selected cases of:  Myopia Hyperopia Astigmatism  Options include:  LASIK PRK SMILE for selected refractive ranges Other laser platforms depending on region

LASIK LASIK reshapes the corneal stroma using an excimer laser beneath a flap. Advantages:  Rapid visual recovery Minimal discomfort  Potential complications include:  Dry eye Flap complications Ectasia Night-vision symptoms Residual refractive error

PRK PRK removes corneal epithelium before stromal ablation. Advantages:  No flap May be preferred with thinner corneas or certain occupational considerations  Disadvantages:  More postoperative discomfort Slower recovery Haze risk

SMILE Small-incision lenticule extraction is primarily used for:  Myopia Myopic astigmatism  depending on regulatory approval and platform. Potential advantages include:  No large corneal flap Less early corneal nerve disruption than LASIK in some cases

Refractive Surgery Limits Older fixed rules such as:  “LASIK corrects up to 10 D myopia” “6 D hyperopia” “4 D astigmatism”  are oversimplified. Eligibility depends on:  Corneal thickness Tomography Optical zone Residual stromal bed Age Stability Dry eye Pupil size Device approval

Phakic Intraocular Lens Phakic IOLs are useful for selected patients with:  High myopia Thin corneas Refractive errors outside comfortable laser ranges  Advantages include:  Excellent optical quality Preservation of accommodation  Potential risks include:  Cataract Endothelial cell loss IOP elevation Intraocular inflammation Infection

Clear Lens Extraction Refractive lens exchange may be considered in selected adults with:  Very high hyperopia Presbyopia Lens-related anatomy unsuitable for corneal surgery  However, it sacrifices: Natural accommodation and carries intraocular surgical risks.

High Myopia and Lens Extraction In younger highly myopic patients, refractive lens exchange deserves caution because of: Retinal detachment risk and loss of accommodation. Phakic IOLs are often preferable when anatomy permits.

Intrastromal Corneal Ring Segments Corneal ring segments are not routinely used simply to correct ordinary low myopia anymore. Their modern role is primarily in selected cases of:  Keratoconus Corneal ectasia  to regularize corneal shape.

Follow-Up in Children Children with significant refractive error should be monitored for:  Visual acuity Amblyopia Strabismus Refractive progression  Children with progressing myopia may also benefit from: Serial axial length measurement when available.

Follow-Up in High Myopia Patients with high myopia require attention to:  Peripheral retina Macula Optic nerve IOP  New:  Flashes Floaters Curtain/shadow Sudden visual decline  require urgent retinal evaluation.

Age-Related Changes Myopia Childhood myopia often progresses through:  School years Adolescence  and may continue into early adulthood. Progression is not guaranteed to stop at age 18.

Hyperopia Children often undergo: Partial emmetropization with decreasing hyperopia during early development. Later symptoms may increase as accommodation declines.

Astigmatism With Aging An important correction: The typical age-related trend is often a shift from: With-the-rule astigmatism in younger adults → against-the-rule astigmatism in older adults rather than increasing with-the-rule astigmatism with age.

Spectacle Intolerance If new spectacles are not tolerated, check:  Prescription accuracy Pupillary distance Optical centers Cylinder axis Lens fabrication Frame fit Vertex distance Pantoscopic tilt Face-form wrap  Also compare with the patient’s:  Habitual prescription

Large Prescription Changes Rapid large changes in:  Sphere Cylinder Axis  may be difficult to adapt to. Before arbitrarily reducing the prescription, confirm:  Refraction accuracy Ocular pathology Corneal shape

Anisometropia and Spectacle Tolerance There is no absolute rule that adults cannot tolerate more than: 2 D of anisometropia Some patients tolerate more, while others tolerate less. Tolerance depends on:  Optical magnification differences Age Duration Binocular function Lens type  Contact lenses substantially reduce spectacle-induced aniseikonia.

Prognosis Most refractive errors can be corrected to: Normal or near-normal visual acuity provided there is no:  Amblyopia Corneal disease Retinal disease Optic nerve disease  The major long-term concern is not refractive blur itself but associated structural disease, especially in: High axial myopia.

Ophthalmology Pearls  Myopia focuses distant light in front of the retina, hyperopia behind the retina, and astigmatism produces different focal powers in different meridians. Most clinically important high myopia is caused by excessive axial elongation. Young hyperopes may hide substantial refractive error through accommodation, making cycloplegic refraction especially important. Cycloplegic refraction is essential in children with significant hyperopia, accommodative esotropia, unexplained reduced vision, or suspected accommodative spasm. Children with accommodative esotropia generally require full cycloplegic hyperopic correction initially. Significant anisometropia and astigmatism in children can cause amblyopia even when neither eye has obvious structural disease. Deliberately undercorrecting childhood myopia is not an evidence-based myopia-control strategy and may worsen progression. Modern childhood myopia control includes low-dose atropine, orthokeratology, dual-focus/multifocal contact lenses, specialized spectacle lenses, and increased outdoor time. Increasing outdoor exposure is one of the best-supported strategies for reducing the risk of myopia onset. High myopia increases risk of retinal detachment, myopic maculopathy, CNV, glaucoma, cataract, and tractional macular disease. High myopia and pathologic myopia are not synonymous; pathologic myopia implies structural degenerative change. Hyperopia is associated with accommodative esotropia, amblyopia, and increased angle-closure risk. Irregular or progressively increasing astigmatism should raise suspicion for keratoconus or corneal ectasia. Astigmatism generally shifts with age from with-the-rule toward against-the-rule. Rigid or scleral contact lenses are particularly useful for irregular astigmatism, because they create a regular refractive surface. Modern refractive surgery candidacy cannot be defined by simple fixed diopter limits; it depends on corneal tomography, thickness, ocular surface, refractive stability, and platform-specific parameters. Phakic IOLs are an important option for high refractive errors with otherwise healthy phakic eyes, particularly when corneal laser surgery is unsuitable. Large anisometropia is often better tolerated with contact lenses than spectacles because contact lenses reduce magnification/minification differences.

Ophthalmology – Recurrent Corneal Erosion Syndrome

Basics

Description

Recurrent corneal erosion syndrome (RCES) is characterized by repeated episodes of spontaneous breakdown of corneal epithelium caused by abnormal epithelial adhesion to the underlying basement membrane/Bowman layer.

The classic presentation is:

Sudden severe unilateral eye pain on awakening or with the first eye opening in the morning

associated with:

• Tearing
• Photophobia
• Foreign-body sensation
• Redness
• Blurred vision

RCES may be:

• Traumatic
• Associated with epithelial basement membrane dystrophy (EBMD)
• Less commonly associated with other corneal dystrophies or ocular-surface disorders

Key Clinical Concept

The fundamental abnormality is:

Failure of the corneal epithelium to form stable adhesion complexes with the underlying basement membrane

During sleep:

• Tear production falls
• Eyelid and corneal epithelium become relatively adherent
• Sudden lid opening creates shearing force

resulting in:

Avulsion of poorly adherent epithelium

Epidemiology

The true incidence is unknown because:

• Mild episodes may never reach medical attention
• Symptoms may be misdiagnosed as dry eye or abrasion

RCES typically affects:

• Young to middle-aged adults

It is usually:

• Unilateral after trauma
• More likely bilateral when associated with EBMD

Etiology

The two major causes are:

1. Previous corneal trauma
2. Epithelial basement membrane dystrophy

Traumatic RCES

Previous trauma is one of the most common causes.

Typical injuries include:

• Fingernail scratch
• Paper edge
• Tree branch
• Leaf
• Other organic material

The original injury may have occurred:

Weeks, months, or even years earlier

and the patient may initially forget it.

Traumatic erosions usually recur:

At the same corneal location.

Epithelial Basement Membrane Dystrophy

EBMD, also called:

• Map-dot-fingerprint dystrophy
• Anterior basement membrane dystrophy

is the most common corneal dystrophy associated with RCES.

Characteristic findings include:

• Map-like lines
• Dot-like epithelial microcysts
• Fingerprint lines
• Negative fluorescein staining
• Loose epithelium

EBMD is often:

• Bilateral
• Asymmetric

Other Corneal Dystrophies

RCES may occasionally occur with:

• Reis-Bücklers corneal dystrophy
• Thiel-Behnke corneal dystrophy
• Lattice corneal dystrophy
• Granular corneal dystrophy
• Meesmann epithelial corneal dystrophy

Risk Factors

Factors associated with RCES include:

• Previous corneal trauma
• EBMD
• Dry eye disease
• Meibomian gland dysfunction
• Blepharitis
• Ocular rosacea
• Diabetes mellitus
• Nocturnal lagophthalmos
• Prior corneal refractive surgery
• Exposure keratopathy

Pathophysiology

Normal corneal epithelium adheres to the underlying basement membrane through:

• Hemidesmosomes
• Anchoring filaments
• Anchoring fibrils

In RCES these structures may be:

• Reduced
• Abnormal
• Poorly organized

resulting in unstable epithelial attachment.

Basement Membrane Abnormality

In EBMD, abnormal basement membrane may extend:

Anteriorly into the epithelial layer

and trap epithelial cells.

This produces:

• Microcysts
• Maps
• Fingerprint lines
• Poor epithelial adhesion

Matrix Metalloproteinases

Increased activity of:

• MMP-2
• MMP-9

has been implicated in degradation of epithelial adhesion structures.

This provides the rationale for using:

Oral tetracyclines such as doxycycline

in selected recurrent or refractory cases.

Why Episodes Occur on Awakening

During sleep:

• Tear secretion decreases
• The ocular surface becomes relatively dry
• The upper lid may adhere to unstable corneal epithelium

When the patient opens the eye:

The lid pulls the weakly attached epithelium away from Bowman membrane

causing abrupt pain and epithelial breakdown.

Clinical Presentation

Symptoms include:

• Severe sharp pain
• Foreign-body sensation
• Tearing
• Photophobia
• Redness
• Blepharospasm
• Blurred vision

Episodes may last:

• Minutes
• Hours
• Occasionally several days

Characteristic History

The classic patient reports:

“My eye is extremely painful when I first open it in the morning.”

The recurrent nature and morning timing are highly suggestive.

Frequency

Episodes may occur:

• Rarely
• Every few months
• Weekly
• Repeatedly within short periods

The severity may vary substantially between episodes.

Examination During an Acute Episode

Findings may include:

• Conjunctival injection
• Lid edema
• Tearing
• Blepharospasm
• Reduced visual acuity

Corneal findings range from subtle epithelial irregularity to a large epithelial defect.

Microform Erosion

A microform erosion may show:

• Punctate epithelial disturbance
• Small area of fluorescein staining
• Loose or irregular epithelium

Symptoms may nevertheless be severe.

Macroform Erosion

A macroform erosion causes:

• Large epithelial defect
• Positive fluorescein staining
• Loose surrounding epithelium
• Occasionally an epithelial flap or tag

Negative Fluorescein Staining

An important sign is:

Negative fluorescein staining

This occurs when elevated or abnormal epithelium disrupts the normal tear film, producing a dark area against surrounding fluorescent tear film.

It may identify:

• EBMD
• Loose epithelium
• Microcysts

The abnormal epithelial area may extend well beyond the obvious positive-staining defect.

Slit-Lamp Examination Between Episodes

The cornea may appear:

Almost normal

between attacks.

Careful examination should look for:

• Map lines
• Fingerprint lines
• Epithelial dots
• Microcysts
• Subtle loose epithelium

Use:

• Retroillumination
• Oblique illumination
• Broad-beam fluorescein examination

Location

Traumatic RCES typically recurs at:

The original injury site

EBMD-related erosions may occur at:

• Different corneal locations
• Either eye

The lower central cornea is commonly involved.

Diagnosis

Diagnosis is primarily:

Clinical

based on:

• Typical history
• Recurrent morning pain
• Slit-lamp evidence of unstable epithelium
• Previous trauma or EBMD

Routine laboratory or imaging studies are not required.

Corneal Sensation

Check corneal sensation when the course is atypical.

Reduced sensation raises concern for:

• Herpes simplex keratitis
• Neurotrophic keratopathy
• Trigeminal dysfunction

Anterior Segment OCT

AS-OCT is not routinely required.

It may occasionally help demonstrate:

• Irregular epithelium
• Basement membrane abnormalities

but diagnosis remains clinical.

In Vivo Confocal Microscopy

Confocal microscopy may demonstrate:

• Epithelial microcysts
• Abnormal basement membrane
• Altered subbasal nerves
• Anterior stromal changes

However:

These findings are not sufficiently specific to diagnose RCES routinely.

Differential Diagnosis

Important differentials include:

• Acute corneal abrasion
• Herpes simplex epithelial keratitis
• Infectious keratitis
• Dry eye disease
• Exposure keratopathy
• Neurotrophic keratopathy
• Meesmann dystrophy
• Bullous keratopathy
• Band keratopathy
• Salzmann nodular degeneration
• Trichiasis
• Subtarsal foreign body
• Recurrent foreign-body exposure
• Contact lens-related epithelial disease

RCES vs Herpes Simplex Keratitis

HSV epithelial keratitis may produce:

• Recurrent pain/redness
• Dendritic epithelial ulcer
• Reduced corneal sensation

RCES usually produces:

• Mechanical epithelial defect
• No true dendritic branching pattern
• Normal sensation unless another disorder coexists

Steroids should not be started casually if HSV is possible.

RCES vs Infectious Keratitis

Infectious keratitis is suggested by:

• Stromal infiltrate
• Purulent discharge
• Significant anterior chamber reaction
• Progressive focal ulceration
• Contact lens-related risk

A simple epithelial defect without infiltrate favors RCES.

Treatment Principles

Management has two goals:

1. Heal the acute epithelial defect
2. Prevent recurrence by improving epithelial adhesion

Treatment progresses from:

• Conservative therapy

to:

• Bandage contact lens

to:

• Procedural treatment for refractory disease

Acute Episode – Lubrication

Initial therapy usually includes:

• Frequent preservative-free artificial tears
• Lubricating ointment

Ointment is particularly useful:

At bedtime

to reduce friction during eyelid opening.

Hypertonic Saline

Hypertonic sodium chloride may improve epithelial adhesion by reducing epithelial edema.

Options include:

• Hypertonic drops during daytime
• 5% sodium chloride ointment at bedtime

It is commonly continued for:

Several months after the acute erosion heals

in recurrent disease.

Analgesia

Pain management may include:

• Oral acetaminophen
• Oral NSAIDs when appropriate
• Cycloplegic drops for significant photophobia or ciliary spasm

Topical Anesthetic Warning

Topical anesthetic may be used during examination but should generally:

Never be supplied for repeated unsupervised home use

because abuse can cause:

• Severe epithelial toxicity
• Nonhealing ulceration
• Stromal melt
• Infection

Topical Antibiotics

When a significant epithelial defect is present, a topical antibiotic may be used until re-epithelialization.

Common choices include:

• Antibiotic ointment
• Preservative-free antibiotic drops when appropriate

The purpose is:

Secondary infection prevention, not treatment of the underlying RCES.

Eye Patching

Routine pressure patching is:

No longer generally recommended

for RCES or uncomplicated corneal abrasions.

It provides little proven benefit and can:

• Delay assessment
• Increase infection concerns

Long-Term Lubrication

After epithelial healing, preventive therapy often consists of:

• Preservative-free tears during the day
• Lubricating or hypertonic ointment before sleep

for weeks to months.

This is first-line prevention for mild disease.

Treat Associated Ocular Surface Disease

Correct contributing factors such as:

• Blepharitis
• Meibomian gland dysfunction
• Dry eye
• Ocular rosacea
• Nocturnal lagophthalmos

This may substantially reduce recurrence.

Eyelid Hygiene

For associated MGD/blepharitis:

• Warm compresses
• Lid hygiene

may improve tear-film quality and reduce epithelial stress.

Bandage Contact Lens

For recurrent disease not controlled by lubrication, a:

Bandage soft contact lens (BCL)

may protect the epithelium from eyelid shear while adhesion complexes reform.

It may be used for:

• Several weeks

depending on severity and response.

BCL Advantages

A bandage lens can:

• Reduce pain
• Protect epithelium
• Promote healing
• Reduce mechanical trauma during blinking

BCL Safety

Because extended lens wear increases risk of:

Microbial keratitis

patients require:

• Close follow-up
• Strict hygiene
• Appropriate topical antibiotic prophylaxis while a significant epithelial defect is present or according to specialist protocol

Patients should return urgently for:

• Increased pain
• Increasing redness
• Discharge
• Reduced vision

Doxycycline

Oral doxycycline can be useful in recurrent or refractory RCES, particularly with:

• MGD
• Rosacea
• Chronic inflammation

Its benefit may reflect:

• MMP inhibition
• Anti-inflammatory action

rather than simply antimicrobial activity.

Doxycycline + Topical Steroid

A commonly used approach in recalcitrant RCES is:

Oral doxycycline + a short course of topical corticosteroid

to suppress:

• MMP activity
• Ocular surface inflammation

This is especially useful in patients with:

• MGD
• Rosacea

Treatment should be supervised because topical steroids can:

• Raise IOP
• Delay epithelial healing
• Worsen infection or HSV

Tetracycline Precautions

Doxycycline is generally avoided in:

• Pregnancy
• Patients with important tetracycline contraindications

Pediatric use depends on:

• Age
• Dose
• Clinical context

Autologous Serum Tears

For difficult recurrent disease, autologous serum tears may provide:

• Lubrication
• Growth factors
• Epitheliotrophic support

They can be useful in:

• Refractory epithelial instability
• Persistent epithelial defects

When to Consider a Procedure

Procedural treatment is appropriate when:

• Frequent recurrences persist despite lubrication
• BCL therapy fails
• Symptoms are severe
• Quality of life is significantly affected

Choice depends strongly on whether the abnormal epithelium is:

• Central
• Peripheral

Epithelial Debridement

Loose epithelium may be mechanically removed.

Simple debridement alone can relieve an acute episode, but:

Recurrence rates are relatively high if the abnormal basement membrane is not also treated.

Therefore it is often combined with:

• Diamond-burr polishing
• Other adhesion-promoting procedures

Diamond-Burr Superficial Keratectomy

Epithelial debridement with diamond-burr polishing of Bowman layer is one of the most effective procedures for recurrent RCES, particularly when:

• EBMD is present
• Lesions involve the visual axis

The procedure:

• Removes loose epithelium
• Smooths abnormal basement membrane/Bowman surface
• Promotes formation of stronger adhesion complexes

Diamond-Burr Advantages

Advantages include:

• High success rate
• Relatively low recurrence
• Can be used for central disease

Potential complications include:

• Transient haze
• Pain during healing
• Infection
• Refractive change

Anterior Stromal Puncture

Anterior stromal puncture (ASP) creates small scars that anchor epithelium more firmly to Bowman layer/anterior stroma.

It is best suited for:

Peripheral erosions outside the visual axis.

Why ASP Is Avoided Centrally

ASP can produce:

• Permanent punctate stromal scars
• Glare
• Reduced visual quality

Therefore it should generally:

Not be performed over the central visual axis.

Phototherapeutic Keratectomy

Phototherapeutic keratectomy (PTK) uses an excimer laser to remove abnormal:

• Epithelium
• Superficial Bowman layer

It is particularly useful for:

• Central recurrent erosions
• EBMD
• Disease refractory to simpler procedures

PTK Advantages

PTK provides:

• Precise superficial ablation
• Smooth optical surface
• Good recurrence control

PTK Risks

Potential complications include:

• Corneal haze
• Hyperopic shift
• Astigmatic change
• Recurrence
• Rare infection

The refractive effect depends on:

• Ablation depth
• Treatment diameter

Alcohol Delamination

Alcohol delamination uses dilute ethanol to loosen and remove abnormal epithelium.

It may:

• Remove diseased epithelium cleanly
• Allow regeneration of a more normal epithelial basement membrane

It remains a reasonable option in selected specialist practice, although diamond-burr polishing and PTK are more commonly emphasized in many modern treatment algorithms.

Post-Procedural Care

After debridement, diamond burr, PTK, or alcohol delamination:

• Bandage contact lens
• Topical antibiotic
• Preservative-free lubrication

are commonly used until epithelial healing.

A topical steroid may be used selectively after epithelial closure depending on:

• Procedure
• Haze
• Inflammation

Nocturnal Lagophthalmos

If episodes are associated with incomplete eyelid closure during sleep, management may include:

• Nighttime ointment
• Moisture chamber
• Eyelid taping in selected cases
• Treatment of underlying exposure disease

Prevention

Protective eyewear should be used for activities with risk of:

• Fingernail injury
• Plant/branch trauma
• Occupational debris

Prevention of the original epithelial injury can reduce traumatic RCES.

Follow-Up

During an acute large erosion, follow-up depends on:

• Defect size
• Pain
• Infection risk
• BCL use

Patients with a bandage contact lens or large defect often require review within:

24–48 hours

initially.

Long-Term Monitoring

Monitor for:

• Recurrence frequency
• Epithelial healing
• Stromal haze
• Infection
• Underlying EBMD
• Dry eye/MGD

Treatment response can be assessed by documenting:

• Frequency of attacks
• Duration
• Severity

Prognosis

The overall prognosis is:

Very good

Most patients eventually achieve substantial reduction or complete cessation of episodes with:

• Lubrication
• Ocular surface optimization
• BCL
• Procedural therapy when necessary

Recurrence

Recurrence remains possible after any treatment, particularly with:

• Diffuse EBMD
• Persistent dry eye
• MGD
• Continued ocular surface trauma

Repeat treatment is occasionally necessary.

Complications

Potential complications include:

• Infectious keratitis
• Corneal stromal haze
• Corneal scar
• Persistent epithelial defect
• Reduced vision
• Rare stromal thinning

The risk of infectious keratitis is increased with:

• Bandage contact lens use
• Topical steroid misuse
• Poor follow-up

Ophthalmology Pearls

• RCES causes recurrent breakdown of poorly adherent corneal epithelium, classically producing severe pain when the eye is first opened after sleep.
• The two major causes are previous corneal trauma and epithelial basement membrane dystrophy (EBMD).
• Traumatic erosions usually recur at the same site, whereas EBMD-related erosions may occur at multiple sites and may be bilateral.
• Look carefully for map-dot-fingerprint changes, microcysts, loose epithelium, and negative fluorescein staining.
• RCES results from abnormal epithelial adhesion involving hemidesmosomes, basement membrane, and anchoring fibrils.
• Increased MMP-2 and MMP-9 activity provides a rationale for doxycycline therapy in selected refractory cases.
• First-line prevention is preservative-free lubrication with nighttime ointment, often supplemented by hypertonic sodium chloride.
• Routine pressure patching is not generally recommended.
• Never provide topical anesthetic drops for repeated unsupervised home use because abuse can cause severe toxic keratopathy and corneal melt.
• A bandage contact lens can be highly effective for persistent disease but requires close follow-up because of microbial keratitis risk.
• Doxycycline plus a short topical steroid course can be useful in recalcitrant RCES, especially when MGD or rosacea is present.
• For persistent disease, diamond-burr superficial keratectomy is highly effective and can be used for central EBMD-related erosions.
• Anterior stromal puncture is best reserved for peripheral lesions outside the visual axis because it leaves small scars.
• PTK is an effective option for central or refractory disease but may cause haze or refractive shift.
• Simple epithelial debridement alone has a higher recurrence rate than procedures that also address the abnormal basement membrane/Bowman surface.
• Always reconsider HSV keratitis or infectious keratitis when an erosion behaves atypically or fails to heal as expected.
• Most patients ultimately achieve excellent symptom control with appropriately escalated therapy.

Ophthalmology – Radiation Retinopathy

Basics

Description

Radiation retinopathy is a delayed, progressive occlusive retinal microangiopathy caused by previous therapeutic radiation involving the eye, orbit, or adjacent head and neck structures.

It may follow:

• Plaque brachytherapy
• Proton-beam therapy
• External-beam radiotherapy
• Stereotactic radiotherapy
• Other radiation delivered sufficiently close to the retina

The disorder resembles diabetic retinopathy because radiation damages the retinal capillary circulation, producing:

• Microaneurysms
• Retinal hemorrhages
• Cotton-wool spots
• Capillary nonperfusion
• Radiation macular edema
• Retinal neovascularization
• Vitreous hemorrhage
• Neovascular glaucoma

The major cause of vision loss is usually:

Radiation maculopathy with macular edema and/or macular ischemia.

Clinical Importance

Radiation retinopathy may remain asymptomatic until:

• Macular edema develops
• Macular ischemia becomes significant
• Neovascular complications occur

Modern management is centered largely on:

Intravitreal anti-VEGF therapy

for radiation maculopathy and retinal neovascularization.

This is a major change from older treatment paradigms that relied primarily on focal/grid laser.

Terminology

Radiation Retinopathy

Refers broadly to radiation-induced retinal microvascular disease.

Radiation Maculopathy

Refers specifically to radiation-induced vascular injury involving the macula, often causing:

• Macular edema
• Ischemia
• Hemorrhage
• Exudation

Radiation maculopathy is the most common vision-threatening manifestation.

Epidemiology

Incidence depends on:

• Total radiation dose
• Dose per fraction
• Radiation modality
• Volume of retina exposed
• Macular dose
• Optic disc dose
• Follow-up duration
• Patient vascular risk factors

Because onset may be delayed by years, prevalence increases with longer follow-up.

Latency

Radiation retinopathy generally appears:

Months to years after treatment

A common interval is approximately:

1–3 years

but onset may be:

• Earlier after high-dose exposure
• Delayed for many years

Therefore a remote history of ocular or orbital radiotherapy remains clinically relevant.

Risk Factors

Important risk factors include:

• Higher retinal radiation dose
• Larger dose per fraction
• Greater macular exposure
• Greater optic disc exposure
• Larger irradiated retinal volume
• Diabetes mellitus
• Hypertension
• Concurrent chemotherapy
• Preexisting retinal vascular disease
• Previous vascular compromise

Diabetes

Diabetes substantially increases susceptibility because both:

• Diabetes
• Radiation

damage the retinal microcirculation.

Patients with diabetes may develop:

• Earlier disease
• More severe macular edema
• More extensive ischemia

after a comparable radiation exposure.

Radiation Dose

With conventional fractionated radiotherapy, retinal toxicity becomes increasingly likely as cumulative retinal dose rises, particularly beyond approximately:

45–50 Gy

Risk is also influenced heavily by:

• Fraction size
• Exact retinal volume irradiated

There is no single completely “safe” retinal dose.

Brachytherapy

Radiation retinopathy is an important delayed complication of plaque treatment for:

• Choroidal melanoma
• Other selected intraocular tumors

Risk increases when the tumor lies close to:

• Fovea
• Optic disc

because these structures receive higher radiation doses.

Pathophysiology

Radiation causes:

Direct DNA injury + free-radical formation + microvascular endothelial damage

The retinal capillary endothelium is particularly vulnerable.

Capillary Injury

Radiation damages:

• Endothelial cells
• Pericytes
• Capillary basement membrane

leading to:

• Capillary incompetence
• Microaneurysm formation
• Vascular leakage
• Capillary closure

Retinal Ischemia

Progressive capillary occlusion produces:

Retinal nonperfusion

which drives expression of:

• VEGF
• Other angiogenic mediators

This may eventually cause:

• Retinal neovascularization
• NVD
• NVE
• NVI
• Neovascular glaucoma

Blood-Retinal Barrier Breakdown

Endothelial dysfunction produces:

• Leakage
• Intraretinal fluid
• Lipid exudation
• Cystoid macular edema

This is the basis of:

Radiation macular edema

and explains the effectiveness of VEGF inhibition.

Clinical Presentation

Patients may initially be:

Asymptomatic

Symptoms depend on the retinal region involved.

Possible complaints include:

• Blurred central vision
• Metamorphopsia
• Central scotoma
• Reduced contrast sensitivity
• New floaters
• Sudden visual loss from vitreous hemorrhage

Visual Loss

Vision may decline from:

• Macular edema
• Macular ischemia
• Foveal atrophy
• Vitreous hemorrhage
• Tractional retinal detachment
• Neovascular glaucoma
• Concurrent radiation optic neuropathy

Fundus Findings

Early findings may include:

• Microaneurysms
• Telangiectatic capillaries
• Dot-blot hemorrhages
• Cotton-wool spots
• Hard exudates

Later findings include:

• Capillary nonperfusion
• Macular edema
• Vascular sheathing
• Retinal neovascularization
• Optic disc neovascularization
• Vitreous hemorrhage

Microaneurysms

Microaneurysms are often among the earliest visible abnormalities.

They may appear:

• Around the macula
• Near irradiated tumor margins
• Within regions of vascular injury

Cotton-Wool Spots

Cotton-wool spots represent:

Focal retinal nerve fiber layer ischemia

and indicate significant microvascular compromise.

Retinal Hemorrhages

Hemorrhages may be:

• Dot-blot
• Flame-shaped
• Preretinal in proliferative disease

The overall pattern can closely mimic diabetic retinopathy.

Hard Exudates

Hard exudates result from chronic vascular leakage and may accumulate:

• Around microaneurysms
• Around the fovea

forming circinate patterns.

Radiation Macular Edema

Macular edema is a major cause of reduced central vision.

OCT may show:

• Intraretinal cysts
• Diffuse retinal thickening
• Subretinal fluid in selected cases
• Hyperreflective exudates

Macular Ischemia

Capillary closure involving the foveal circulation may produce:

• Enlarged or irregular FAZ
• Reduced capillary density
• Permanent central visual loss

Unlike edema:

Established macular ischemia has no proven restorative treatment.

Proliferative Radiation Retinopathy

Severe ischemia may result in:

• NVD
• NVE
• Preretinal hemorrhage
• Vitreous hemorrhage

This represents the proliferative stage.

Anterior Segment Neovascularization

Extensive retinal ischemia may cause:

• Neovascularization of the iris
• Neovascularization of the angle

leading to:

Neovascular glaucoma

Radiation Retinopathy vs Radiation Optic Neuropathy

Both may occur after ocular radiation.

Radiation Retinopathy

Primarily affects:

• Retinal microvasculature

Findings include:

• Microaneurysms
• Hemorrhages
• Exudates
• Macular edema
• Nonperfusion

Radiation Optic Neuropathy

Primarily affects:

• Optic nerve
• Chiasm

and produces:

• Dyschromatopsia
• RAPD
• Visual field loss
• Optic atrophy

Both disorders may coexist.

Diagnosis

Diagnosis is based on:

• Prior radiation exposure
• Compatible retinal examination
• Characteristic multimodal imaging
• Exclusion of competing vascular causes

History

Important questions include:

• Original tumor diagnosis
• Radiation modality
• Total dose
• Fractionation
• Date of treatment
• Plaque location if brachytherapy
• Tumor distance from fovea and disc
• Diabetes
• Hypertension
• Chemotherapy
• Previous retinal disease

Radiation oncology records are very useful when available.

Slit-Lamp Examination

Assess for:

• NVI
• Hyphema
• Cataract
• Radiation-related ocular surface disease

Intraocular Pressure

Measure IOP because severe ischemic disease may progress to:

Neovascular glaucoma

Gonioscopy

Perform gonioscopy when:

• NVI is present
• IOP is elevated
• Neovascular glaucoma is suspected

Look for:

• NVA
• PAS
• Angle closure

Dilated Fundus Examination

Evaluate:

• Macula
• Posterior pole
• Peripheral retina
• Optic nerve
• Neovascularization

Look specifically for:

• Hemorrhages
• Cotton-wool spots
• Microaneurysms
• Exudates
• Vascular attenuation
• NVD/NVE

Optical Coherence Tomography

OCT is the principal test for detecting and monitoring radiation maculopathy.

It demonstrates:

• Intraretinal fluid
• Cystoid spaces
• Subretinal fluid
• Retinal thickness
• Outer retinal damage
• Atrophy

Serial OCT is central to anti-VEGF treatment decisions.

OCT Angiography

OCTA can demonstrate:

• Capillary dropout
• Enlarged FAZ
• Superficial plexus abnormalities
• Deep capillary plexus abnormalities
• Neovascular complexes

It is especially useful for:

Early microvascular disease before dramatic funduscopic changes develop.

Fluorescein Angiography

FA may demonstrate:

• Microaneurysms
• Telangiectasia
• Capillary nonperfusion
• Enlarged FAZ
• Macular leakage
• NVD/NVE leakage

Wide-field FA can be particularly useful for quantifying:

Peripheral retinal ischemia.

Fundus Photography

Fundus photography is useful for documenting:

• Hemorrhage
• Exudation
• Neovascularization
• Evolution over time

Differential Diagnosis

Important differentials include:

• Diabetic retinopathy
• Retinal vein occlusion
• Hypertensive retinopathy
• Ocular ischemic syndrome
• Retinal artery occlusive disease
• Sickle cell retinopathy
• Retinal vasculitis
• Purtscher-like retinopathy
• Other ischemic retinopathies

Radiation Retinopathy vs Diabetic Retinopathy

The retinal appearance can be nearly identical.

Radiation retinopathy is favored by:

• Previous radiation exposure
• Distribution matching radiation field
• Unilateral/asymmetric disease after unilateral treatment
• Lack of comparable systemic diabetic retinal disease

A diabetic patient can, of course, have:

Both conditions simultaneously.

Radiation Retinopathy vs Retinal Vein Occlusion

Vein occlusion typically produces:

• Venous dilation/tortuosity
• Sectoral or diffuse hemorrhage pattern
• Corresponding venous drainage distribution

Radiation retinopathy tends to produce a more chronic microangiopathic pattern related to the irradiated retina.

Treatment Principles

Treatment is aimed at:

• Controlling macular edema
• Suppressing neovascularization
• Preventing vitreous hemorrhage
• Preventing neovascular glaucoma

Damage from established retinal nonperfusion itself is:

Usually irreversible.

Anti-VEGF Therapy

The modern first-line treatment for vision-threatening radiation maculopathy is:

Intravitreal anti-VEGF therapy

Common agents include:

• Bevacizumab
• Ranibizumab
• Aflibercept
• Other VEGF-inhibiting agents depending on availability

Anti-VEGF Effects

Anti-VEGF therapy may:

• Reduce macular edema
• Improve retinal thickness
• Stabilize visual acuity
• Improve vision in some patients
• Suppress retinal/iris neovascularization

Chronic Treatment Requirement

Radiation maculopathy is usually a:

Chronic disease

and anti-VEGF benefit frequently requires:

• Repeated injections
• Long-term surveillance

Stopping treatment may lead to:

• Recurrent edema
• Progressive vascular damage
• Visual decline

Treatment Regimens

Common approaches include:

• Fixed interval dosing
• PRN dosing
• Treat-and-extend strategies

Treatment is guided by:

• OCT fluid
• Visual acuity
• Hemorrhage
• Disease recurrence

Important Treatment Principle

Radiation maculopathy may require:

More persistent anti-VEGF treatment than many patients initially expect.

The goal is often:

Preservation of vision, rather than permanent cure.

Prophylactic Anti-VEGF

In patients receiving plaque brachytherapy for uveal melanoma, some centers use prophylactic intravitreal anti-VEGF injections before clinically apparent radiation maculopathy develops.

This strategy may:

• Delay macular edema
• Reduce severity of radiation maculopathy
• Improve long-term visual preservation

However:

Prophylactic anti-VEGF is not universally required or standardized for every irradiated eye.

Use depends on:

• Tumor location
• Macular radiation dose
• Patient risk
• Institutional protocol

Intravitreal Corticosteroids

Steroids may be useful for:

• Persistent radiation macular edema
• Incomplete anti-VEGF response

Options include:

• Dexamethasone implant
• Other intravitreal steroid approaches

Steroid Risks

Potential complications include:

• IOP elevation
• Cataract
• Infection

Therefore steroids are generally used selectively.

Focal/Grid Laser

Focal or grid laser was historically a major treatment for radiation macular edema.

Its role is now:

Much more limited

because anti-VEGF therapy generally provides better control of center-involving edema.

Laser may still have a role in selected:

• Non-center-involving focal leakage
• Chronic cases not suitable for injections

Panretinal Photocoagulation

PRP is indicated for significant proliferative radiation retinopathy, particularly when there is:

• NVD
• NVE
• Extensive ischemia with neovascular complications

Its purpose is to reduce:

Retinal ischemic VEGF drive

Anti-VEGF + PRP

For active neovascularization:

• Anti-VEGF produces rapid regression
• PRP provides more durable ischemia control

The combination is especially useful with:

• NVI
• NVA
• Neovascular glaucoma

Neovascular Glaucoma

Management includes:

• Intravitreal anti-VEGF
• PRP
• Aqueous suppressant medications
• Glaucoma surgery when necessary

Anti-VEGF alone is temporary because it does not eliminate the underlying retinal ischemia.

Vitrectomy

Pars plana vitrectomy may be required for:

• Nonclearing vitreous hemorrhage
• Recurrent vitreous hemorrhage
• Tractional retinal detachment
• Combined tractional/rhegmatogenous detachment
• Epiretinal traction in selected cases

Macular Ischemia

No established treatment restores retinal tissue lost from:

Macular capillary nonperfusion

Anti-VEGF may reduce coexisting edema but cannot reliably reverse established foveal ischemia.

Systemic Risk-Factor Control

Optimize:

• Diabetes
• Hypertension
• Dyslipidemia
• Smoking status
• Other vascular risk factors

This does not reverse radiation damage but may reduce additive microvascular stress.

Prevention

The most important preventive strategy is:

Minimizing unnecessary radiation exposure to the retina and macula during treatment planning.

Techniques include:

• Careful dosimetry
• Conformal radiation planning
• Shielding when feasible
• Plaque placement optimization
• Proton-beam targeting
• Fractionation where appropriate

Post-Radiation Surveillance

Patients receiving significant retinal radiation exposure should undergo:

Long-term ophthalmic surveillance

because disease may appear years after treatment.

Follow-Up

Frequency depends on:

• Radiation dose
• Tumor location
• Macular involvement
• Current retinal findings
• Active treatment

Stable high-risk patients may be examined every:

3–6 months

while active macular edema or neovascular disease often requires much closer follow-up.

Monitoring

Assess:

• Visual acuity
• IOP
• Slit-lamp examination
• NVI
• Gonioscopy when indicated
• Dilated fundus examination
• OCT

Use FA/OCTA when:

• Ischemia needs characterization
• Neovascularization is uncertain

Prognosis

Radiation retinopathy is:

Chronic and potentially progressive

Visual prognosis depends heavily on:

• Macular radiation dose
• Degree of macular ischemia
• Optic nerve involvement
• Time to treatment
• Response to anti-VEGF
• Development of neovascular complications

Early Treatment

Modern anti-VEGF therapy has substantially improved visual outcomes compared with historical observation or laser-only treatment.

Best outcomes occur when:

Macular edema is detected and treated before severe irreversible ischemic or structural damage develops.

Poor Prognostic Features

Poor visual prognosis is associated with:

• Severe macular ischemia
• Extensive capillary nonperfusion
• Chronic untreated edema
• Foveal atrophy
• Radiation optic neuropathy
• Vitreous hemorrhage
• Neovascular glaucoma
• Retinal detachment

Complications

Important complications include:

• Radiation macular edema
• Macular ischemia
• Retinal neovascularization
• NVD/NVE
• Vitreous hemorrhage
• Tractional retinal detachment
• NVI/NVA
• Neovascular glaucoma
• Permanent central visual loss
• Concurrent radiation optic neuropathy

Ophthalmology Pearls

• Radiation retinopathy is a delayed occlusive retinal microangiopathy after radiation involving the eye, orbit, or adjacent head and neck structures.
• The pathology resembles diabetic retinopathy because radiation produces endothelial injury, capillary leakage, and progressive nonperfusion.
• Typical findings include microaneurysms, cotton-wool spots, retinal hemorrhages, hard exudates, macular edema, and later neovascularization.
• Radiation maculopathy is the major cause of visual loss, particularly through macular edema and ischemia.
• Disease most commonly appears 1–3 years after radiation, but substantially later onset is possible.
• Risk increases with higher retinal dose, larger fraction size, macular/optic-disc exposure, diabetes, hypertension, and chemotherapy.
• OCT is the key modern test for radiation macular edema, while FA and OCTA demonstrate capillary nonperfusion and vascular abnormalities.
• Intravitreal anti-VEGF is now first-line treatment for vision-threatening radiation maculopathy, replacing focal/grid laser as the mainstay for center-involving edema.
• Anti-VEGF treatment is often chronic and repeated; interruption may lead to recurrent edema and visual deterioration.
• Intravitreal corticosteroids may help selected anti-VEGF–refractory cases but carry risks of IOP elevation and cataract.
• Prophylactic anti-VEGF after plaque brachytherapy is used in selected high-risk eyes and may delay radiation maculopathy, but it is not a universal requirement.
• PRP remains important for proliferative radiation retinopathy and retinal ischemia producing neovascularization.
• NVI/NVA should be managed with rapid anti-VEGF plus definitive retinal ischemia treatment with PRP, along with glaucoma therapy.
• Vitrectomy is reserved for complications such as nonclearing vitreous hemorrhage and tractional retinal detachment.
• Established macular ischemia is generally irreversible, so early detection of edema and vascular injury is critical.
• Patients require long-term surveillance, because radiation retinopathy may develop years after apparently successful cancer treatment.

Ophthalmology – Radiation Optic Neuropathy

Basics

Description

Radiation-induced optic neuropathy (RION) is a delayed, usually severe optic neuropathy caused by previous radiation exposure to the:

• Optic nerve
• Optic chiasm
• Occasionally optic tract

It most often occurs after radiotherapy for tumors involving or adjacent to the anterior visual pathway, including:

• Orbit
• Paranasal sinuses
• Skull base
• Sella/parasellar region
• Nasopharynx
• Intracranial tumors near the optic apparatus

The typical presentation is:

Sudden or rapidly progressive, painless visual loss months to years after radiotherapy

RION is usually irreversible and must be distinguished urgently from:

Recurrent or progressive tumor, which may require specific treatment.

Clinical Importance

New visual loss in a patient with previous radiation near the optic pathways should prompt urgent evaluation for:

• Radiation-induced optic neuropathy
• Recurrent/compressive tumor
• Tumor infiltration
• Optic neuritis
• Ischemic optic neuropathy
• Meningeal carcinomatosis
• Radiation retinopathy

The diagnosis should not be assumed solely because of a history of radiotherapy.

Epidemiology

RION is uncommon with modern radiation planning but remains a serious delayed complication.

Risk is strongly related to:

• Total radiation dose
• Dose per fraction
• Volume of optic nerve/chiasm irradiated
• Radiation technique
• Patient-specific vascular susceptibility

Latency

RION most often develops:

Several months to several years after treatment

A common interval is approximately:

1–3 years

but cases may occur earlier or substantially later.

A very long latency does not completely exclude RION.

Laterality

Disease may be:

• Unilateral
• Sequentially bilateral
• Bilateral simultaneously

If the chiasm is involved, both eyes may be affected through:

• Chiasmal field loss
• Bilateral optic nerve dysfunction

Risk Factors

Important risk factors include:

• High radiation dose to the optic apparatus
• Large dose per fraction
• Stereotactic/high-dose focal treatment near optic nerve or chiasm
• Re-irradiation
• Concurrent or prior chemotherapy
• Diabetes mellitus
• Hypertension
• Preexisting optic nerve compression
• Other vascular risk factors

Radiation Dose and Risk

For conventional fractionated radiotherapy, the risk of RION rises substantially when the optic nerve or chiasm receives doses above approximately:

50–55 Gy

particularly when:

• Fraction size exceeds approximately 1.8–2 Gy
• Large segments of the optic pathway are irradiated

Modern radiation planning generally attempts to keep maximum optic nerve/chiasm dose below established organ-at-risk constraints whenever tumor control allows.

Stereotactic Radiosurgery

The optic nerve and chiasm are particularly sensitive to:

High single-fraction doses

Therefore single-fraction radiosurgery immediately adjacent to a functioning optic apparatus requires strict dose limitation.

Fractionated stereotactic radiotherapy may be preferred when a lesion lies very close to:

• Optic nerve
• Chiasm

because fractionation reduces the risk of delayed radiation injury.

Pathophysiology

RION is believed to result from a combination of:

• Radiation-induced vascular injury
• Endothelial damage
• Capillary occlusion
• Ischemia
• Demyelination
• Direct glial and axonal injury

Vascular Injury

Radiation damages small blood vessels through:

• Endothelial proliferation
• Fibrinoid necrosis
• Obliterative endarteritis
• Capillary closure

The result is:

Chronic ischemia of the optic nerve

Parenchymal Injury

Radiation may also directly damage:

• Oligodendrocytes
• Astrocytes
• Myelin
• Axons

leading to:

• Demyelination
• Necrosis
• Axonal loss

The final pathology is therefore both:

Vascular and neural.

Clinical Presentation

The classic symptom is:

Painless visual loss

which may be:

• Sudden
• Subacute
• Rapidly progressive over days to weeks

Vision loss is often severe.

Visual Acuity

Visual acuity may decline to:

• 20/200 or worse
• Counting fingers
• Hand motions
• No light perception in severe cases

Visual prognosis is generally poor once substantial injury is established.

Color Vision

Patients commonly have:

Marked dyschromatopsia

consistent with optic nerve dysfunction.

Pupillary Findings

If involvement is unilateral or asymmetric:

Relative afferent pupillary defect (RAPD)

is expected.

Bilateral symmetric disease may produce no obvious RAPD.

Visual Fields

Field defects depend on the location of injury.

Optic Nerve

Possible defects include:

• Central scotoma
• Cecocentral scotoma
• Arcuate defect
• Altitudinal defect
• Diffuse depression

Optic Chiasm

May produce:

• Bitemporal hemianopic defects

Optic Tract

May produce:

• Contralateral homonymous visual field loss

Optic Disc Appearance

At onset, the optic disc may appear:

• Normal
• Mildly swollen
• Pale if there was prior compressive damage

Anterior optic nerve involvement may produce:

Disc edema

but many cases are retrobulbar and initially have a normal-appearing disc.

Optic Atrophy

Over subsequent weeks:

Optic disc pallor develops

because of irreversible axonal loss.

This may be accompanied by:

• RNFL thinning
• Ganglion cell loss

Radiation Retinopathy

RION may coexist with:

Radiation retinopathy

especially when the globe was within the radiation field.

Look for:

• Microaneurysms
• Cotton-wool spots
• Retinal hemorrhages
• Macular edema
• Capillary nonperfusion
• Neovascularization

Concurrent retinal disease may contribute to visual loss.

Diagnosis

RION is principally a:

Diagnosis of clinical context + characteristic imaging + exclusion of recurrent tumor and other causes

There is no single laboratory test that confirms it.

History

Obtain detailed information about:

• Original tumor
• Radiation field
• Total radiation dose
• Fraction size
• Radiation modality
• Date of treatment
• Re-irradiation
• Chemotherapy
• Prior visual function

Radiation treatment records are extremely useful if available.

MRI – Investigation of Choice

Obtain:

MRI of the brain and orbits with and without contrast

with:

• Thin orbital sections
• Fat-suppressed postcontrast imaging
• Dedicated evaluation of optic nerves and chiasm

MRI Findings

Characteristic findings may include:

• Focal or segmental enhancement of the affected optic nerve
• Chiasmal enhancement
• T2 hyperintensity
• Mild nerve enlargement in some cases

Enhancement may involve only a short segment and can be missed if imaging is not optimized.

Important MRI Principle

Enhancement of an irradiated optic nerve is:

Not specific for RION

because similar enhancement can occur with:

• Tumor infiltration
• Optic neuritis
• Sarcoidosis
• Infection
• Perineuritis

Therefore imaging must be interpreted in the clinical context.

Excluding Tumor Recurrence

One of the most important goals of imaging is to exclude:

• Recurrent tumor
• Progressive tumor
• New compressive lesion
• Radiation-induced secondary neoplasm

Serial comparison with previous MRI is particularly valuable.

OCT

Optical coherence tomography is useful for documenting structural injury.

Assess:

• Peripapillary RNFL
• Macular GCIPL/GCC

Early disease may show:

• RNFL thickening if disc edema is present

Later disease typically shows:

• RNFL thinning
• Ganglion cell loss

Ganglion Cell Analysis

Macular GCIPL/GCC may reveal:

Early retrograde axonal degeneration

and can be useful for:

• Baseline documentation
• Monitoring progression
• Correlating structural loss with visual fields

Visual Fields

Automated perimetry should be performed whenever visual function permits.

It helps:

• Localize the lesion
• Document severity
• Monitor progression

Fluorescein Angiography

FA is not routinely required for isolated RION but is useful when evaluating:

• Concurrent radiation retinopathy
• Macular ischemia
• Retinal vascular leakage

Laboratory Evaluation

Laboratory testing is directed by the differential diagnosis rather than RION itself.

Consider testing for:

• Inflammatory disease
• Infection
• Giant cell arteritis in appropriate older patients
• Nutritional/toxic causes

when the clinical picture is atypical.

Lumbar Puncture

CSF examination may be considered when there is concern for:

• Meningeal carcinomatosis
• Malignant infiltration
• Inflammatory optic neuropathy
• Infection

It is not routinely required for classic RION.

Differential Diagnosis

Important differentials include:

• Recurrent or progressive tumor
• Compressive optic neuropathy
• Tumor infiltration of optic nerve
• Meningeal carcinomatosis
• Optic neuritis
• Anterior ischemic optic neuropathy
• Posterior ischemic optic neuropathy
• Radiation retinopathy
• Sarcoidosis
• Optic perineuritis
• Toxic/nutritional optic neuropathy
• Paraneoplastic optic neuropathy
• Radiation-induced secondary tumor

RION vs Recurrent Tumor

RION

Usually:

• Delayed after radiotherapy
• Relatively abrupt visual decline
• Segmental optic pathway enhancement
• No progressively enlarging mass

Recurrent Tumor

More likely:

• Progressive mass on serial imaging
• Increasing compression
• Associated cranial neuropathies
• Progressive orbital or neurologic signs

The distinction may occasionally require:

• Serial MRI
• Multidisciplinary neuroradiology review

RION vs Optic Neuritis

RION

• History of radiation
• Usually older or tumor-treated population
• Often profound vision loss
• Usually little or no pain
• Poor recovery

Typical Optic Neuritis

• Often younger patient
• Pain with eye movement common
• Demyelinating context
• Greater likelihood of spontaneous recovery

RION vs NAION

NAION typically has:

• Acute painless visual loss
• Disc edema at onset
• Altitudinal field defect
• Crowded fellow optic disc

RION may have:

• Normal disc at onset
• Retrobulbar segmental enhancement
• Prior radiation exposure

Treatment

There is currently:

No treatment of consistently proven efficacy for established RION.

This remains one of the most important clinical realities.

Corticosteroids

Systemic corticosteroids have been used empirically.

However:

There is no convincing evidence that corticosteroids reliably restore vision in RION.

They may be considered if:

• Inflammatory optic neuropathy remains in the differential

but should not be presented as established treatment for radiation injury.

Hyperbaric Oxygen Therapy

Hyperbaric oxygen has been used because of the hypothesis that increasing tissue oxygenation may improve ischemic injury.

Potential benefit appears most plausible when initiated:

Very early after visual loss

before irreversible optic nerve infarction develops.

However:

• Evidence is limited
• Results are inconsistent
• Controlled data are lacking

Therefore HBO remains:

Unproven and controversial

rather than standard therapy.

Anti-VEGF Therapy

Intravitreal or systemic anti-VEGF therapy has been reported in small series and case reports.

A theoretical rationale is reduction of:

• Vascular permeability
• Radiation-associated microvascular leakage

However:

Anti-VEGF is not established therapy for isolated RION.

It is much better established for:

• Radiation maculopathy
• Radiation retinopathy

Bevacizumab

Some small reports have described visual stabilization or improvement with bevacizumab, particularly in anterior radiation optic neuropathy with associated disc edema.

Evidence remains insufficient for routine recommendation.

Anticoagulation

Anticoagulants and antiplatelet drugs have been tried based on the vascular hypothesis.

There is:

No established evidence of benefit

for routine use solely for RION.

Pentoxifylline and Vitamin E

These agents have been studied for other radiation-induced tissue injuries.

Their role in RION remains:

Unproven.

Surgical Treatment

There is no surgical treatment for the radiation injury itself.

Surgery may be required only when imaging reveals another treatable cause such as:

• Recurrent compressive tumor
• Radiation-induced mass

Prevention

Because treatment is unreliable:

Prevention is the most important strategy.

Radiation Planning

Preventive measures include:

• Respecting optic nerve/chiasm dose constraints
• Minimizing fraction size
• Using conformal planning
• IMRT
• Proton therapy in selected cases
• Fractionated stereotactic techniques when close to optic pathways
• Avoiding unnecessary re-irradiation

Multidisciplinary Planning

Treatment planning near the optic apparatus should involve:

• Radiation oncology
• Neurosurgery
• Neuro-ophthalmology when appropriate

The goal is to balance:

Tumor control against risk of irreversible visual pathway injury.

Follow-Up After Radiation Near the Optic Pathways

Patients should be educated to report:

• New blurred vision
• Color desaturation
• Visual field loss
• Sudden monocular or binocular visual change

promptly.

Clinical surveillance may include:

• Visual acuity
• Color vision
• Pupillary testing
• Visual fields
• OCT